|
Tuesday, November 19, 2019
Print Entire 2019 Program:
 |
|
| SESSION 1 SCHEDULE | |
|
Tuesday
SESSION 1:
PROGRESS IN THE TREATMENT OF ASCENDING AORTIC DISEASE, TRANSCATHETER VALVE REPLACEMENT AND CORONARY ARTERY STENTING
Moderators:Hazim J. Safi, MD / Joseph S. Coselli, MD
|
|
| x | |
| 6:45 AM - 6:50 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| CORONARY STENTS | |
| 6:50 AM - 6:55 AM | What Is New In Coronary Stenting: Current Status Of Non-Absorbable Stents, Drug Eluting And Bare Metal |
| Presenter(s):Gregg W. Stone, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Update Of Bioabsorbable Stents (BRSs) In The Coronary Arteries: Why Did The Absorb Stent Fail: Is There Hope For BRSs In The Future – In Coronary Or Peripheral Arteries |
| Presenter(s):Gregg W. Stone, MD | |
| View Slides in PDF | |
| THE ASCENDING AORTA | |
| 7:02 AM - 7:07 AM | Current Status Of Endovascular Treatment For Ascending Aortic Lesions: What Patients, What Pathology, What Devices Exist |
| Presenter(s):Grayson H. Wheatley, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:14 AM | Update On Ascending Aortic Endograft Treatment: Indications, Devices, Techniques And Results |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 7:15 AM - 7:21 AM | Status Of Endovascular Combined Device For Repairing Lesions Of The Ascending Aorta And The Aortic Valve: The Endo-Bentall Concept |
| Presenter(s):Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 7:22 AM - 7:28 AM | Will New Ascending Aortic Endografts Enable Treatment Of Type A Aortic Dissections: What Percentage Of Patients: What Is Here And What Is The Future |
| Presenter(s):Alan B. Lumsden, MD, FACS | |
| View Slides in PDF | |
| TRANSCATHETER HEART VALVES | |
| 7:29 AM - 7:29 AM | Progress In Transcatheter Aortic Valve Replacement (TAVR): An Interventional Cardiologist’s View. This presentation will be given by Martin B. Leon on Thursday, Session 47 at 7:03 to 7:98 a.m. in the Grand Ballroom East. |
| 7:29 AM - 7:35 AM | Progress In TAVR: A Cardiac Surgeon’s View: What Is The Current Place For Open Surgical Aortic Valve Replacement |
| Presenter(s):Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 7:36 AM - 7:42 AM | Progress In Endovascular Mitral Valve Repair: What Devices Are Appearing And How Well Are They Working |
| Presenter(s):Juan F. Granada, MD | |
| View Slides in PDF | |
| 7:43 AM - 7:51 AM | Panel Discussion |
| END OF SESSION 1 | |
| SESSION 2 SCHEDULE | |
|
Tuesday
SESSION 2:
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
Moderators:Eric E. Roselli, MD / Ali Khoynezhad, MD, PhD
|
|
| x | |
| 7:51 AM - 7:56 AM | With Aortic Arch Lesions (Aneurysms And Dissections), When Should The Treatment Be Fenestrated Or Branched TEVAR (F/B/TEVAR), Chimney TEVAR (Ch/TEVAR), Hybrid Or Fully Open Surgical Repair |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 7:57 AM - 8:02 AM | Another View Of Current Optimal Treatment Of Aortic Arch Aneurysms: Total Endovascular, Hybrid, Open And Frozen Elephant Trunk: Which Is Best When |
| Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 8:03 AM - 8:08 AM | Update On Value And Limitations Of Frozen Elephant Trunk Repairs And The ThoroFlex Graft For Complex Aortic Arch Lesions: Is Spinal Cord Ischemia An Issue |
| Presenter(s):Joseph S. Coselli, MD | |
| View Slides in PDF | |
| 8:09 AM - 8:14 AM | Six-Year Results With Terumo Aortic Relay 2 Branched Device For Aortic Arch Lesions: Indications And Contraindications |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 8:15 AM - 8:20 AM | Update On Total Endovascular Arch Repairs Using Cook Multibranched Devices: When Indicated, When Questionable, When Not Indicated; Advantages And Limitations |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:21 AM - 8:26 AM | Total Endovascular Aortic Arch Repairs With The Relay 2-Branched Endograft: The US Experience – Advantages And Limitations |
| Presenter(s):Eric E. Roselli, MD | |
| View Slides in PDF | |
| 8:27 AM - 8:32 AM | Physician-Made Fenestrated Endograft Repair For Aortic Arch Lesions: Experience In >115 Cases: Challenges And Technical Tips |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 8:33 AM - 8:38 AM | Experience With Branched Endografts For Treatment Of Aortic Arch Lesions |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| View Slides in PDF | |
| 8:39 AM - 8:44 AM | Long-Term Results (>4 Years) Of Parallel Grafts (Chimneys And Periscopes) For Aortic Arch Lesions; Tips To Make Them Work And When Do They |
| Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:45 AM - 8:50 AM | Results And Advantages With A Precurved Convertible F/B Endograft For Arch Lesions: How It Compares With Other Arch Grafts And Will It Be Available Outside Japan |
| Presenter(s):Yoshihiko Yokoi, MD | |
| View Slides in PDF | |
| 8:51 AM - 8:56 AM | Real World Experience With Double Branched Endografts For Aortic Arch Lesions: Are They Ready For Prime Time: From The Italian And Dutch Registries |
| Presenter(s):Piergiorgio Cao, MD, FRCS / Ciro Ferrer, MD | |
| View Slides in PDF | |
| 8:57 AM - 9:04 AM | Panel Discussion |
| END OF SESSION 2 | |
| SESSION 3 SCHEDULE | |
|
Tuesday
SESSION 3:
PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: PETTICOAT, STABILISE, FLIRT, FENESTRATIONS AND TEVAR’S EFFECTS ON THE HEART
Moderators:Rodney A. White, MD / Michael J. Jacobs, MD
|
|
| x | |
| 9:04 AM - 9:09 AM | Evolving An Optimal Treatment For Type B Aortic Dissections (TBADs) With TEVAR And False Lumen Embolization: TechniqueS And Results |
| Presenter(s):Weiguo Fu, MD | |
| View Slides in PDF | |
| 9:10 AM - 9:15 AM | Fenestration And Branched EVAR (F/B/VAR) To Treat Post TBAD AAAs: Technical Tips, Results And Limitations |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | Update On PETTICOAT TEVAR For TBADs: Why The Addition Of A Distal Bare Dissection Stent To A Proximal Covered Stent Facilitates Treatment And Improves Outcomes |
| Presenter(s):Joseph V. Lombardi, MD | |
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Impact Of The PETTICOAT Technique (With A Distal Bare Stent Added To A Proximal Covered Stent) On Aortic Remodeling With Chronic TBADs: Indications, Timing Of Treatment And Results |
| Presenter(s):Chun Che Shih, MD, PhD | |
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | The STABILISE Modification Of The PETTICOAT Technique To Rupture The Dissection Flap And Promote False Lumen Obliteration To Treat TBADs: Concept, Indications And Results |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Another Opinion About The STABILISE Modification Of The PETTICOAT Technique To Disrupt The Dissection Flap With A Compliant Balloon In The Covered Stent And A Non-Compliant Balloon In The Bare Stent: Precautions And Results |
| Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | Long Stent Grafts For TEVAR Have Bad Effects On The Heart And Tend To Migrate Proximally Causing Type 1B Endoleaks: What Are The Mechanisms |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | Update On Extensive Flap Disruption (Fenestration) To Treat TBADs: Why It Works By Equalizing Pressure In The 2 Lumens, Indications And Results |
| Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD | |
| View Slides in PDF | |
| 9:52 AM - 9:57 AM | Open Surgical Flap Excision In The Abdominal Aorta To Treat Complex Dissections: Indications, Theory, Technique, Precautions And Results |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC | |
| View Slides in PDF | |
| 9:57 AM - 10:11 AM | Panel Discussion |
| 10:11 AM - 10:21 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 3 | |
| SESSION 4 SCHEDULE | |
|
Tuesday
SESSION 4:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
Moderators:Nicholas J.W. Cheshire, MD / Frank J. Veith, MD
|
|
| x | |
| 10:21 AM - 10:26 AM | Evidence For And Risks Of Endovascular Treatment Of Asymptomatic Acute Type B Aortic Dissection: Is TEVAR Really A Good Treatment |
| Presenter(s):Rachel E. Clough, MD, PhD, FRCS | |
| View Slides in PDF | |
| 10:27 AM - 10:32 AM | Long-Term Successful Treatment Of TBADs With Total Aortic Remodeling Usually Requires Multiple Re-Interventions – Many Long After The Original TEVAR: What Are These Re-Interventions |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 10:33 AM - 10:38 AM | A New Classification System For Aortic Dissections: Better For Prognosis, Predicting Complications And Guiding Treatment |
| Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD | |
| View Slides in PDF | |
| 10:39 AM - 10:44 AM | F/B/EVAR Treatment Of Chronic TBADs With An Enlarging AAA After TEVAR: A Positive 8-Year Experience; How To Deal With A Small True Lumen And Value Of Inner Branches |
| Presenter(s):Marcelo Ferreira, MD | |
| View Slides in PDF | |
| 10:45 AM - 10:50 AM | How To Manage Re-Entry Sites In The Arch And Visceral Segment Of The Aorta After TEVAR For TBADs |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 10:51 AM - 10:56 AM | Update On False Lumen Occlusion Techniques And Value After TEVAR For TBADs: New Devices; When Indicated; Results And When Preferred Over F/B/EVAR In Patients With AAAs |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 10:57 AM - 11:02 AM | Effectiveness Of False Lumen Embolization For Chronic TBADs With Progressive Aortic Enlargement: Devices, Techniques And Results |
| Presenter(s):Herve Rousseau, MD, PhD | |
| View Slides in PDF | |
| 11:03 AM - 11:08 AM | A New Modular Branched Stent-Graft For Aortic Arch Reconstruction: Advantages And Limitations From A First In Man Study |
| Presenter(s):Wei Guo, MD | |
| View Slides in PDF | |
| 11:09 AM - 11:15 AM | Panel Discussion |
| 11:15 AM - 11:20 AM | Improvements In Techniques And Grafts For Open TAAA Repair: In Virginal Cases And After Failed Endovascular Procedures |
| Presenter(s):Hazim J. Safi, MD | |
| View Slides in PDF | |
| 11:21 AM - 11:26 AM | Open TAAA Repair After Failed TEVAR Or Endovascular TAAA Repair: Technical Advances And Results: Who Should Do These Redo Procedures |
| Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 11:27 AM - 11:32 AM | Importance Of A Type III Aortic Arch And Descending Aorta Tortuosity In Determining Outcomes Of TEVAR And Treating TBADs: How To Deal With These Issues |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 11:33 AM - 11:38 AM | Current Status Of Cerebral Protection For TEVAR And TAVR: What Are The Devices, When Can They Help And When Not |
| Presenter(s):Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 11:39 AM - 11:44 AM | Staged Endovascular And Open TAAA Repairs Reduces Morbidity And Mortality: When And How To Do It And Results |
| Presenter(s):Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD | |
| View Slides in PDF | |
| 11:45 AM - 11:50 AM | TEVAR Has Better Long-Term Survival (>5 Years) Than Open Repair For Intact Descending Thoracic Aortic Aneurysms: TEVAR Should Be The Standard Of Care; Randomized Trials (RCTs) Are Not Needed |
| Presenter(s):Michael D. Dake, MD | |
| View Slides in PDF | |
| 11:51 AM - 11:56 AM | Short And Long-Term Comparison In Canada Of Open And Endo TAAA Repair Regarding Outcomes And Cost: Endo Is Best |
| Presenter(s):Thomas F. Lindsay, MDCM, FRCS, FACS | |
| View Slides in PDF | |
| 11:57 AM - 12:03 PM | Panel Discussion |
| 12:03 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 4 | |
| SESSION 5 SCHEDULE | |
|
Tuesday
SESSION 5:
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING)
Moderators:Kim J. Hodgson, MD / Ronald L. Dalman, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | How And Why Is AAA Disease Different In Diabetics: How Do These Differences Impact Treatment |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Update On The Nellix Graft And EVAS: Will Nellix Be A Failure Or A Phoenix Surmounting Its Problems |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Why Are AAA Patients Surviving More: What Is Its Impact On Screening And Size Criteria For Repair |
| Presenter(s):Anders Wanhainen, MD, PhD / Jes S. Lindholt, MD | |
| 1:18 PM - 1:23 PM | Value Of Metformin And Ticagrelor In Inhibiting The Growth Of Small AAAs: What Is The Long-Term Fate Of 25-29 mm Abdominal Aortas: How Many Will Become AAAs |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| SHORT SUMMARY TOPICS (3-4 MINUTES) | |
| 1:24 PM - 1:28 PM | Influence Of Metformin On AAA Derived Cells In Culture: A Clue To How Metformin Slows AAA Growth |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 1:28 PM - 1:32 PM | Update On The Value Of And Indications For Pre EVAR Lumbar And Inferior Mesenteric Artery Embolization |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 1:32 PM - 1:36 PM | DEBATE: There Are Several Good Reasons To Electively Repair AAAs <5.5 cm In Maximum Diameter: What Are They |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:40 PM | DEBATE: Why AAAs < 5.5 cm Should Not Be Treated Invasively: The Rupture Rate (< 1%/Year) Is Less Than Commonly Thought |
| Presenter(s):Jonothan J. Earnshaw, FRCS | |
| View Slides in PDF | |
| 1:40 PM - 1:45 PM | Panel Discussion |
| Moderator(s): Mark A. Adelman, MD / Michel Makaroun, MD | |
| 1:45 PM - 1:50 PM | DEBATE: Young Fit AAA Patients Have Better Long-Term Survival With Open Repair (OR) Than EVAR And Should Be Offered OR If They Need Invasive Treatment |
| Presenter(s):Andrew W. Bradbury, MD, FRCSEd | |
| View Slides in PDF | |
| 1:51 PM - 1:56 PM | DEBATE: Not So: Survival Is Better In Young Fit AAA Patients After EVAR Than OR |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 1:57 PM - 2:02 PM | Why Open Repair Of AAAs Has Improving Outcomes: When Is OR Indicated And Better For Patients |
| Presenter(s):Thomas C. Bower, MD | |
| View Slides in PDF | |
| 2:03 PM - 2:08 PM | In AAA Patients Suitable For Both OR And EVAR Unfavorable Neck Characteristics (Short, Wide, Angulated Or Cone Shaped) Have More Adverse Outcomes And Higher Mortality After OR As Well As EVAR: From The DREAM RCT: How Should This Impact On AAA Treatment Decisions |
| Presenter(s):Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 2:09 PM - 2:14 PM | Migration Patterns In Newer Lower Profile EVAR Stent-Grafts: What Are The Implications For EVAR Planning And Follow-Up |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 2:15 PM - 2:20 PM | Optimal Current Treatment For Inflammatory AAAs: When Medical; When Endo; When Open |
| Presenter(s):Franco Grego, MD | |
| View Slides in PDF | |
| 2:21 PM - 2:26 PM | EVAS Treated Patients (With Nellix) Have A Lower 3-Year Mortality Than EVAR Treated Patients: What Is The Mechanism And Is This Difference Restricted To Patients With AAAs >5.5 cm |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 2:27 PM - 2:32 PM | Another View Of Why EVAS Treated Patients (With Nellix) Have A Lower Mortality Than EVAR Treated Patients: What Is The Mechanism And Is This Difference Restricted To Patients With AAAs >5.5 cm |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 2:33 PM - 2:38 PM | Panel Discussion |
| END OF SESSION 5 | |
| SESSION 6 SCHEDULE | |
|
Tuesday
SESSION 6:
MORE ABOUT AAAs AND EVAR; THE NICE GUIDELINES AND REACTIONS TO THEM
Moderators:Ali F. AbuRahma, MD / Frank J. Veith, MD
|
|
| x | |
| 2:38 PM - 2:43 PM | Highlights Of Clinical Practice Guidelines For Endovascular Repair Of Complex AAAs Involving The Paravisceral Aorta |
| Presenter(s):Thomas L. Forbes, MD | |
| View Slides in PDF | |
| 2:44 PM - 2:49 PM | Sac Shrinkage Is A Good Marker Of Durable Success After EVAR: Is There A Difference In This Marker With Different Endografts |
| Presenter(s):Michael C. Stoner, MD | |
| View Slides in PDF | |
| 2:50 PM - 2:55 PM | Long-Term Results Of EVAR Outside Device IFUs Is Not So Bad: When Is It Acceptable To Use EVAR Devices Outside Their IFUs |
| Presenter(s):Bibombe Patrice Mwipatayi, MMed, MClinEd, FCS, FRACS | |
| View Slides in PDF | |
| 2:56 PM - 3:01 PM | When Is EVAR First The Best Option For Repairing AAAs And When Is Open Repair First The Best Option: Late Failures Raise Questions Especially With Large Diameter Necks And Outside The IFUs |
| Presenter(s):Daniel G. Clair, MD | |
| View Slides in PDF | |
| THE UK NICE AAA GUIDELINES AND REACTIONS TO THEM | |
| 3:02 PM - 3:07 PM | Highlights Of The UK NICE Guidelines For Treating Elective And Ruptured AAAs: Why Do They Favor Open Repair Over EVAR And What Was The Influence Of The EVAR 1 Late Results |
| Presenter(s):Andrew W. Bradbury, MD, FRCSEd | |
| View Slides in PDF | |
| 3:08 PM - 3:13 PM | Why The Early Survival Benefit For EVAR Versus Open Repair Outweighs The Late Survival Benefit For Open Repair Versus EVAR |
| Presenter(s):Nicholas J.W. Cheshire, MD | |
| View Slides in PDF | |
| MORE COMMENTS ON THE NICE AAA GUIDELINES | |
| 3:14 PM - 3:18 PM | The NICE AAA Guidelines Are Misleading And Unfairly Biased Against EVAR |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 3:18 PM - 3:22 PM | Why The NICE AAA Guidelines Reached The Wrong Conclusions – That EVAR Benefits Were Not Worth The Costs |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 3:22 PM - 3:26 PM | What Is Right In The NICE AAA Guidelines And What Is Wrong In Them |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 3:26 PM - 3:30 PM | Flaws In The NICE Guidelines For Treating AAAs: How They Were Based On Biases Of The Writing Committee And Why They Will Have An Impact Beyond The UK |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 3:30 PM - 3:36 PM | Panel Discussion |
| 3:36 PM - 3:46 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 6 | |
| SESSION 7 SCHEDULE | |
|
Tuesday
SESSION 7:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC AORTIC PATHOLOGY
Moderators:Ronald L. Dalman, MD / Firas F. Mussa, MD
|
|
| x | |
| 3:46 PM - 3:51 PM | Best Medical Therapy For Acute TBAD Patients: What Is It And Strategies To Optimize It: How Effective Can It Be |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | New Concepts In The Pathogenesis Of TBADs: What Are The Therapeutic Implications: What Is Best Medical Therapy For TBAD: Principles And Paradoxes |
| Presenter(s):David M. Williams, MD | |
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | Technical Tips To Improve Or Increase The Use And Safety Of The Cook T-Branch Off-The-Shelf (OTS) Device For TAAAs |
| Presenter(s):Marcelo Ferreira, MD | |
| View Slides in PDF | |
| 4:04 PM - 4:09 PM | Aortic Arch Anomalies, Especially Bovine Arches: What Are Their Bad Implications For Patients And Treatment Outcomes |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Update On The Natural History Of Penetrating Aortic Ulcers (PAUs) And Intramural Hematomas (IMHs) With And Without TEVAR Treatment: Medical Treatment Has A High Failure Rate: So When And How Should They Be Treated |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 4:16 PM - 4:21 PM | Making EVAR Safer Long-Term Using Ultrasound Made Simple To Measure AAA Sac Diameter At Home |
| Presenter(s):Roger M. Greenhalgh, MD | |
| TIMING OF EVAR FOR UNCOMPLICATED TBAD | |
| 4:22 PM - 4:27 PM | TEVAR Can Be Performed Safely Soon After Symptom Onset With TBADs Under Certain Conditions |
| Presenter(s):Edward Y. Woo, MD / Tareq Massimi, MD | |
| View Slides in PDF | |
| 4:28 PM - 4:33 PM | With Uncomplicated TBADs TEVAR Should Be Performed As Soon As Possible After Onset Of Symptoms: For These Reasons And With These Precautions |
| Presenter(s):Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 4:34 PM - 4:39 PM | Not So: With Uncomplicated Acute TBADs TEVAR Should Be Delayed 2 Weeks To 3 Months For These Reasons |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | With Uncomplicated Acute TBADs TEVAR Should Be Delayed For 1-3 Months After Symptom Onset And Why |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 4:46 PM - 4:53 PM | Panel Discussion |
| END OF SESSION 7 | |
| SESSION 8 SCHEDULE | |
|
Tuesday
SESSION 8:
MORE NEW DEVELOPMENTS RELATING TO TEVAR AND TBADs: CAUSES AND PREVENTION OF STROKE COMPLICATIONS; CONTROVERSIES OVER THE NEED FOR TEVAR IN SOME OR ALL ACUTE UNCOMPLICATED TBAD PATIENTS, AND OVER THE EXTENT OF TEVAR COVERAGE
Moderators:Timur P. Sarac, MD / Mark A. Farber, MD
|
|
| x | |
| 4:53 PM - 4:58 PM | Status Of Stroke Prevention During TEVAR: What Percent Are Due To Particulate Emboli And What Percent Due To Air Emboli: Techniques To Prevent Both |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 4:59 PM - 5:04 PM | Causes Of Stroke During TEVAR: Gaseous Emboli Are Important And Some But Not All Can Be Prevented By CO2 Flushing Of Delivery Systems |
| Presenter(s):Richard G.J. Gibbs, FRCS | |
| View Slides in PDF | |
| 5:05 PM - 5:10 PM | The STEP Registry: A Global Network To Decrease Strokes Associated With Thoracic Aortic Endografting Procedures: How Will It Work |
| Presenter(s):Fiona Rohlffs, MD / Stephan Haulon, MD / Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 5:11 PM - 5:16 PM | IVUS Need Not Be Mandatory To Treat TBADs By TEVAR Safely: How So |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 5:17 PM - 5:22 PM | DEBATE: Most Acute Uncomplicated TBADs Need To Be Treated By TEVAR: The INSTEAD RCT Proves It: We Do Not Need Further RCTs |
| Presenter(s):Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 5:23 PM - 5:28 PM | DEBATE: Not So: Controversy Lingers: We Do Need A RCT Comparing TEVAR With Best Medical Treatment (BMT) To BMT Alone For Acute Uncomplicated TBADs: How Could Such A Trial Be Structured And Financed |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 5:29 PM - 5:34 PM | Why TEVAR For Acute Uncomplicated TBADs Is Imperfect: The Case For Using It Selectively |
| Presenter(s):Joseph V. Lombardi, MD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | DEBATE: Treating More Acute Uncomplicated TBAD Patients With Extended TEVAR Coverage Almost To The Celiac Artery Will Improve Outcomes: It Is The Way To Go |
| Presenter(s):William D. Jordan Jr., MD | |
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | DEBATE: Not So: Limited Coverage Of The Thoracic Aorta By TEVAR Is Safer And Better |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | A Decision-Making Algorithm For Optimally Treating Uncomplicated Acute TBAD Patients |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 5:53 PM - 6:00 PM | Panel Discussion End of Program A |
| END OF SESSION 8 | |
| SESSION 9 SCHEDULE | |
|
Tuesday
SESSION 9:
PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, SIMULATION AND LAPAROSCOPY
Moderators:Alan B. Lumsden, MD, FACS / Jean-Baptiste Ricco, MD, PhD
|
|
| x | |
| VASCULAR ROBOTICS | |
| 6:45 AM - 6:50 AM | A New Vascular Robotic System From Corindus: How Does It Work: What Does It Do: Clinical Experience And Value |
| Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS | |
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | Current Status Of Endovascular Catheter Robotics: What Is Here And What Is Coming |
| Presenter(s):Jean Bismuth, MD / Alan B. Lumsden, MD, FACS | |
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | Will Newer Technology And Platforms Lead To More Widespread Use Of Vascular Robotics: What Is On The Horizon And Beyond |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | A New Vascular Robotic System From China: How Does It Work: Advantages: Cost And When Will It Be Available |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | Robotics In Vascular Surgery: What Is Available; What Is Coming And How Will It Help |
| Presenter(s):Ravi K. Veeraswamy, MD | |
| View Slides in PDF | |
| VASCULAR GUIDANCE | |
| 7:15 AM - 7:20 AM | Machine Learning Based Measurement Of AAA Diameter With Contrast CT: A New And Better Way |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 7:21 AM - 7:26 AM | Update On An Emerging Radiation Free 3D Endovascular Guiding System (IOPS) From Centerline (BIOM) Medical: How Does It Work; When Will We Have It; How Much Will It Cost |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 7:27 AM - 7:32 AM | A New 3D Device Guidance Technology Within The Vascular Tree: Fiber Optic RealShape (FORS Technology): How Does It Work And Initial Results |
| Presenter(s):Joost A. van Herwaarden, MD, PhD | |
| View Slides in PDF | |
| 7:33 AM - 7:38 AM | Is There Real Evidence To Support The Value Of Simulation In Vascular Surgery: Vascular Surgery Endo And Open Is Not Like Piloting An Aircraft |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| LAPAROSCOPY | |
| 7:39 AM - 7:44 AM | Laparoscopic Median Arcuate Ligament Release: The Best Way To Treat Celiac Artery Compression Syndrome: Advantages And Limitations And Who Should Do It |
| Presenter(s):Joseph S. Giglia, MD / George H. Meier, MD | |
| View Slides in PDF | |
| 7:45 AM - 7:50 AM | Why I Stopped Doing Laparoscopic Aortic Surgery After Performing 160 Cases |
| Presenter(s):Laurent Chiche, MD, FEBVS | |
| View Slides in PDF | |
| 7:51 AM - 7:59 AM | Panel Discussion |
| END OF SESSION 9 | |
| SESSION 10 SCHEDULE | |
|
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID DISEASE: UNRESOLVED CONTROVERSIES
Moderators:Bruce A. Perler, MD, MBA / L. Nelson Hopkins, MD
|
|
| x | |
| 7:59 AM - 8:04 AM | Role And Value Of Biomarkers Of Brain Injury In CAS And CEA Procedures: How Can They Help Decision Making |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Systemic Biomarkers Can Predict The Volume Of Cerebral Infarct Associated With Carotid Interventions: Is There A Difference Between CAS And CEA |
| Presenter(s):Wei Zhou, MD | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Cerebral Hyperfusion Syndrome After CAS Procedures: Etiology, Diagnosis, Optimal Treatment And Prevention |
| Presenter(s):Gert J. de Borst, MD, PhD | |
| View Slides in PDF | |
| 8:17 AM - 8:22 AM | Intracranial Artery Dissection: An Unrecognized Cause Of Strokes: How To Diagnose And Treat It |
| Presenter(s):Emmanuel M. Houdart, MD | |
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Eversion CEA: Technical Tips, When Is It The Best Method For CEA And When Not |
| Presenter(s):Timothy M. Sullivan, MD | |
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | New Developments In Best Medical Treatment For Carotid Patients: Can Carotid Plaques Be Stabilized Or Shrunk: Will Strokes And MIs Become Rare Or Eliminated |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | DEBATE: CEA Must Include Completion Imaging With Duplex Or Angiography |
| Presenter(s):Hans-Henning Eckstein, MD, PhD | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | DEBATE: Not So: Completion Duplex Can Be Misleading And Angiography Can Be Harmful And Misleading: Completion Imaging Causes More Harm Than Benefit |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:54 AM | Panel Discussion |
| 8:54 AM - 8:59 AM | Avoiding And Managing Complications During Transfemoral CAS |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM | Optimal Contemporary Treatment Of Carotid Artery Aneurysms, Pseudoaneurysms And Patch Infections: When Endo, When Open |
| Presenter(s):Peter L. Faries, MD, FACS | |
| View Slides in PDF | |
| 9:06 AM - 9:11 AM | How Best In 2019 To Pick Asymptomatic Patients With Unstable Plaques At High Risk Of Having A Stroke: Are There New Duplex Techniques Which Can Help |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
| UPDATE ON CAROTID PATCHES | |
| 9:12 AM - 9:17 AM | Careful Primary Closure Of CEA Arteriotomies (Without A Patch) Is Not Inferior To Patch Closures: In A Propensity Matched Analysis: Why Did The RCTs Get It Wrong |
| Presenter(s):Dong-ik Kim, MD | |
| View Slides in PDF | |
| 9:18 AM - 9:23 AM | All Patches For CEA Closure Are Not Equal: Which Patch Material Is Best: How Big Should The Patch Be: Disadvantages And Complications Of Carotid Patches |
| Presenter(s):Vikram S. Kashyap, MD / Norman Kumins, MD | |
| View Slides in PDF | |
| 9:24 AM - 9:29 AM | Should All CEA Closures Be Patched: Could The RCTs Indicating That All CEA Patients Should Have Patch Closures Be Misleading |
| Presenter(s):Ali F. AbuRahma, MD | |
| View Slides in PDF | |
| 9:30 AM - 9:35 AM | Femoral Vein Interposition Grafts Are The Best Treatment For Patch Infections After CEA: Technical Tips |
| Presenter(s):Salvatore T. Scali, MD / Thomas S. Huber, MD, PhD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | Carotid Interventions CEA And CAS Will Become Obsolete: Why And When |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 9:42 AM - 9:48 AM | Panel Discussion |
| 9:48 AM - 9:58 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 10 | |
| SESSION 11 SCHEDULE | |
|
Tuesday
SESSION 11:
MORE NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; PROGRESS IN THE INTERVENTIONAL MANAGEMENT OF ACUTE STROKES (5 AND SOME 4-MINUTE SHORT SUMMARY [SS] TALKS)
Moderators:Allan L. Brook, MD / Horst Sievert, MD
|
|
| x | |
| 9:58 AM - 10:03 AM | Carotid Plaque Characteristics With Duplex, CT And MRI Can Predict High Stroke Risk Patients With Asymptomatic Carotid Stenosis |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| 10:04 AM - 10:08 AM | [SS] DEBATE: Long-Term Results Of Transfemoral CAS Are Equivalent To Those Of CEA – Maybe Even Better |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 10:08 AM - 10:12 AM | [SS] DEBATE: Not So: Long-Term Results Of CAS Are Not Equal To Those Of CEA |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 10:12 AM - 10:16 AM | [SS] Why Occlusion Of 1 Internal Carotid Artery (ICA) Is Not A Benign Condition Even If The Patient Is Asymptomatic |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| 10:16 AM - 10:21 AM | Value Of CAS In Treating Chronically Totally Occluded ICAs: Indications, Technical Tips, Results |
| Presenter(s):Piotr Myrcha, MD, PhD | |
| View Slides in PDF | |
| 10:22 AM - 10:26 AM | [SS] Limb Shaking TIAs: What Are They, What Imaging Should Be Performed And How Should They Be Treated |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| MANAGEMENT OF ACUTE STROKES | |
| 10:26 AM - 10:31 AM | Merit Of MRI vs. CTA To Evaluate Acute Strokes And Their Treatment: MRI Is Better Than CTA |
| Presenter(s):Emmanuel M. Houdart, MD | |
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | Urgent Interventional Treatment Of Strokes Complicating Cardiac Surgery, TEVAR And Other Endo Interventions: What Should Be Done Diagnostically And Therapeutically: Results |
| Presenter(s):L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | For Acute Strokes Later Thrombus Removal From Intracranial Arteries Can Be Beneficial Even 6-16 Hours After Symptom Onset: What Are The Conditions For Success And In Which Patients |
| Presenter(s):Colin P. Derdeyn, MD | |
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | Mechanical Intracranial Thrombectomy For Acute Strokes Has Worse Results At Low Volume Centers: What Are The Implications And Which Physicians Should Be Performing These Procedures |
| Presenter(s):L. Nelson Hopkins, MD / Colin P. Derdeyn, MD | |
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | Value Of Suction Thrombectomy Versus Stentrievers To Remove Intracranial Arterial Clot: Advantages Of Penumbra Devices (Jet 7 And Jet D) For Acute Stroke Treatment |
| Presenter(s):Colin P. Derdeyn, MD | |
| View Slides in PDF | |
| 10:56 AM - 11:00 AM | [SS] What Is The Role Of The Vascular Surgeon In The Treatment Of Acute Strokes |
| Presenter(s):Laura Capoccia, MD, PhD | |
| View Slides in PDF | |
| 11:00 AM - 11:06 AM | Panel Discussion |
| END OF SESSION 11 | |
| SESSION 12 SCHEDULE | |
|
Tuesday
SESSION 12:
PROGRESS IN THE TREATMENT OF AORTO-ILIAC AND ILIAC OCCLUSIVE DISEASE
Moderators:Keith D. Calligaro, MD / Daniel G. Clair, MD
|
|
| x | |
| 11:06 AM - 11:11 AM | Optimal Endovascular Treatment Of Aorto-Iliac Occlusive Disease: Proper Stent Or Stent-Graft Selection And Technical Tips |
| Presenter(s):Jean Bismuth, MD | |
| View Slides in PDF | |
| 11:12 AM - 11:17 AM | When Are Covered Stents The Best Treatment For Aorto-Iliac Occlusive Disease: Which Is The Best Stent-Graft For This: What Are The Long-Term Results |
| Presenter(s):Bibombe Patrice Mwipatayi, MMed, MClinEd, FCS, FRACS | |
| View Slides in PDF | |
| 11:18 AM - 11:23 AM | Update On The CERAB Procedure (Covered Endovascular Reconstruction of Aortic Bifurcation) For Aorto-Iliac Occlusive Disease: Technical Tips, 3-Year Results, What Is The Best Stent-Graft For This Procedure |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 11:24 AM - 11:29 AM | Value Of The CERAB Procedure For Failed Iliac Stents: Technical Tips And Best Stent-Graft |
| Presenter(s):Maria A. Ruffino, MD, EBIR | |
| View Slides in PDF | |
| 11:30 AM - 11:35 AM | Value Of Aortic (AAA) Endografts For Treatment Of Aorto-Iliac Occlusive Disease: Which Device Is Best And Results |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 11:36 AM - 11:41 AM | What Is The Best Endovascular Device For Aorto-Iliac Occlusive Lesions: When Self-Expanding Stent; When Balloon Expandable Stent; Which Covered Stent And For Which Lesion |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 11:42 AM - 11:47 AM | Thoraco-Bifemoral Bypass Is A Good Solution When Other Techniques Fail Or Are Contraindicated: Technical Tips And Results |
| Presenter(s):Manju Kalra, MBBS | |
| View Slides in PDF | |
| 11:48 AM - 11:53 AM | When Limb Occlusion Occurs After An EVAR, Endovascular Solutions Are The Way To Go: Technical Tips To Make Them Safe And Effective |
| Presenter(s):Klaus M. Overbeck, MD, MPhil | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 12 | |
| SESSION 13 SCHEDULE | |
|
Tuesday
SESSION 13:
NEW OR UPDATED CONCEPTS AND TECHNIQUES; IMPORTANCE OF ARTIFICIAL INTELLIGENCE (AI) IN VASCULAR TREATMENT (5 AND ONE 4-MINUTE SHORT SUMMARY [SS] TALKS)
Moderators:Barry T. Katzen, MD / Ron Waksman, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | The Evidence Base For Clinical Decision Making In Lower Extremity Treatments Is Poor: Guidelines Are Often Based On Shaky Foundations: What Is Needed And Are Things Improving |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Innovation In The Hybrid Operating Room And Angio Suite: What Future Developments Should We Expect: The Philips Azurion Flex C-Arm Fluoroscope Is One Example |
| Presenter(s):Barry T. Katzen, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Advances In Transradial Access For Treating Non-Cardiac Arterial Lesions: Supplies Needed Like Sheathless Systems And 7 Key Technical Pillars To Make Radial Access Procedures Safe And Successful |
| Presenter(s):Marcelo Guimaraes, MD, FSIR | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Update After 2 Years Of The BATTLE RCT Showing Equivalence Of The Zilver PTX DES (Cook) And Misago Bare Stent (Terumo) For Fempop Lesions: Despite The Misago’s Suitability For Deployment Via Radial Access: How Is This Possible |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 1:24 PM - 1:28 PM | [SS] What Is The Cutneedle And How Does It Facilitate Percutaneous Vascular Access |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 1:28 PM - 1:33 PM | The Untethered Vascular Patient: How Sensor Technology And Telemedicine Will Improve Care And The Need For Doctor Visits |
| Presenter(s):Tony S. Das, MD | |
| View Slides in PDF | |
| 1:34 PM - 1:39 PM | New Evidence That Telehealth Virtual Visits Can Change Patient Behavior And Be Beneficial |
| Presenter(s):John (Jeb) W. Hallett, MD | |
| View Slides in PDF | |
| 1:40 PM - 1:45 PM | Lessons Learned By A Creative Physician-Inventor And How Artificial Intelligence Will Change Vascular Practice And The World |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 1:46 PM - 1:51 PM | Relevance Of Cybersecurity And Artificial Intelligence To Endovascular Treatments |
| Presenter(s):Ron Waksman, MD | |
| View Slides in PDF | |
| 1:52 PM - 1:57 PM | How To Use Apps To Improve Vascular Surgery And A Vascular Surgeon’s Practice |
| Presenter(s):Keith D. Calligaro, MD | |
| View Slides in PDF | |
| 1:58 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 13 | |
| SESSION 14 SCHEDULE | |
|
Tuesday
SESSION 14:
VASCULAR SURGERY BRANDING, RECOGNITION, TRAINING AND GOVERNING BODIES (BOARD AND RESIDENCY REVIEW COMMITTEE [RRC])
Moderators:Alan M. Dietzek, MD, RPVI, FACS / Benjamin W. Starnes, MD
|
|
| x | |
| 2:06 PM - 2:11 PM | Vascular Surgeons Should Be Complete Vascular Doctors And Not Just Proceduralists: They Should Be Knowledgeable In And Manage All Aspects Of Non-Cardiac Vascular Disease Care |
| Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Update On Vascular Surgery Training Programs: Number Of 0+5 Positions; Number Of 5+2 Programs: How Many More Of Each Are In The Pipeline |
| Presenter(s):Murray L. Shames, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | How Medical/Hospital Executives Perceive Vascular Surgery: It Is Not As A Separate Specialty: Why We Need To Be A Separate Specialty And To Have The Recognition That Goes With It |
| Presenter(s):Jeffrey H. Hsu, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Are Interventional Cardiologists Competing With Vascular Surgeons: What Are Their Advantages And Disadvantages: What Can Be Done About This Competition |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Why Vascular Surgery Needs An Approved Independent Board And To Be An Independent Specialty: Status Of The American Board of Vascular Surgery Or ABVS And What Progress Is It Making In Its Quest |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | The Reasons Why Vascular Surgery Needs To Be An Independent Specialty With Its Own Separate Board And RRC: It Is Time To Move From Being A Colony To A Nation, Or A Territory To A State |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Vascular Surgery Needs An Independent ABMS Approved Board And RRC To Thrive As A Specialty In The Medical Hierarchy And To Have Its Value Appropriately Recognized |
| Presenter(s):Timothy M. Sullivan, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Vascular Surgery Needs Its Own Separate Approved Board And Qualifies For It In Every Way: However, To Get It The Specialty’s Leadership Represented By The SVS Executive Committee Must Recognize This Need And Go After It With Full Force |
| Presenter(s):O. William Brown, MD, JD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | What Is Wrong With The American Board of Surgery’s MOC (Maintenance Of Certification) System For Vascular Surgeons And What Can Be Done To Fix It |
| Presenter(s):K. Craig Kent, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | The Present MOC System Is Flawed And Does Not Help Patients: MOC Should Be Abolished And Replaced By A Lifelong Learning System: How To Do It |
| Presenter(s):Gilbert R. Upchurch, MD | |
| View Slides in PDF | |
| 3:06 PM - 3:15 PM | Panel Discussion |
| 3:15 PM - 3:26 PM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 14 | |
| SESSION 15 SCHEDULE | |
|
Tuesday
SESSION 15:
NEW DEVELOPMENTS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE (5 AND SOME 4-MINUTE SHORT SUMMARY [SS] TALKS)
Moderators:Ronald M. Fairman, MD / Kenneth Ouriel, MD, MBA
|
|
| x | |
| 3:26 PM - 3:30 PM | [SS] Endovascular Treatment Of Large Renal Aneurysms With An Uncovered Stent Excludes The Aneurysm While Preserving Branch Flow: Does It Work |
| Presenter(s):Jacques Busquet, MD | |
| View Slides in PDF | |
| 3:30 PM - 3:34 PM | [SS] An Occluded Renal Artery Does Not Mean A Lost Kidney Due To Collaterals Maintaining Its Viability: Revascularization Can Restore Function |
| Presenter(s):Wei Zhou, MD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Renal Artery Aneurysms: When Are They Dangerous: Endovascular Techniques For Treatment: When Is Open Repair Indicated |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | Endovascular Versus Open Treatment For Renal And Visceral Artery Aneurysms: When Is Each Treatment Best; Technical Tips |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | Update On Optimal Treatment For Acute Mesenteric Ischemia: When Endo; When Open: Technical Tips |
| Presenter(s):Guillermo A. Escobar, MD | |
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | Isolated Dissection Of The Celiac Axis Or Superior Mesenteric Artery (SMA) May Be Symptomatic Or Asymptomatic: Natural History And How Best To Treat |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | Panel Discussion |
| 4:03 PM - 4:07 PM | [SS] DEBATE: Open Surgery Has An Important Role In The Treatment Of Mesenteric Aneurysms |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 4:08 PM - 4:12 PM | [SS] DEBATE: Not So: Mesenteric And Renal Aneurysms Can All Be Treated Endovascularly: Technical Tips |
| Presenter(s):Robert A. Morgan, MD | |
| View Slides in PDF | |
| 4:13 PM - 4:18 PM | Pancreaticoduodenal Artery Aneurysms: New Insights Into Their Natural History And Treatment: Endo Versus Open |
| Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD | |
| View Slides in PDF | |
| 4:19 PM - 4:24 PM | Embolization Treatment For Splenic Artery Aneurysms: When, When Not, Technical Tips And Long-Term Results |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | Indications And Technical Tips For Safe Retrograde SMA Stenting In Acute Mesenteric Ischemia: Best Access Is Via A Small SMA Branch |
| Presenter(s):Cynthia K. Shortell, MD | |
| View Slides in PDF | |
| 4:31 PM - 4:35 PM | [SS] Direct Percutaneous Approach To Treat Visceral Artery Aneurysms Difficult To Approach Intraluminally: How To Do It Safely |
| Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
| View Slides in PDF | |
| 4:36 PM - 4:42 PM | Panel Discussion |
| END OF SESSION 15 | |
| SESSION 16 SCHEDULE | |
|
Tuesday
SESSION 16:
UPDATE ON OPEN SURGICAL AND HYBRID PROCEDURES; NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC COARCTATION
Moderators:Enrico Ascher, MD / Sebastian E. Debus, MD, PhD
|
|
| x | |
| 4:42 PM - 4:47 PM | Can Simulation Substitute For The Decrease In Open Aortic Cases In Training And Practice |
| Presenter(s):Ashraf Mansour, MD | |
| View Slides in PDF | |
| 4:48 PM - 4:53 PM | When Is Open Surgery The Best Treatment For Visceral Occlusive Disease And Aneurysms And Why |
| Presenter(s):Laurent Chiche, MD, FEBVS | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Technical Tips For Obtaining Open Retroperitoneal Exposure For Treating Complex AAAs Involving The Pararenal And Visceral Aorta |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Long-Term Results Of Open Juxta- And Pararenal AAA Repair: From A Large Multicenter National Database With Mean Follow-Up Of 4 Years |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | Durability And Late Results Of TAAA Repairs For Type IV And Types I-III TAAAs: When Should Open Repair Be The Preferred Treatment In The Current Endo World |
| Presenter(s):Hazim J. Safi, MD | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | Minimal Incisions For Open Aortobifemoral And Fempop Bypasses: Technical Tips And Advantages |
| Presenter(s):Robert M. Proczka, MD, PhD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | Panel Discussion |
| 5:24 PM - 5:29 PM | Is There Still A Role For Hybrid Procedures In The Endo Era: Why And In What Conditions And Vascular Beds |
| Presenter(s):Oscar L. Ojeda, MD, FACS | |
| View Slides in PDF | |
| MID-AORTIC SYNDROME | |
| 5:30 PM - 5:35 PM | Update On Revascularization For Renovascular Hypertension And Mid-Aortic Syndrome: It Is Almost Always Best Treated By Open Surgery |
| Presenter(s):Dawn M. Coleman, MD | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | Renovascular Hypertension And Mid-Aortic Syndrome: There Is A Role For Endovascular As Well As Open Treatments: Which Treatment Is Best At What Ages |
| Presenter(s):George Hamilton, MD, FRCS | |
| View Slides in PDF | |
| ADVANCES IN COARCTATION TREATMENT | |
| 5:42 PM - 5:47 PM | Advances In Covered Stent Treatment Of Aortic Coarctation: Value Of New Balloon Expandable Stent-Grafts: Are Bare Stents Ever Indicated |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 5:48 PM - 5:53 PM | Tips And Tricks For Endo Treatment Of Aortic Coarctation With Aneurysmal Degeneration As A Complication Of A Chronic TBAD |
| Presenter(s):Marcelo Ferreira, MD | |
| View Slides in PDF | |
| 5:54 PM - 6:00 PM | Panel Discussion End of Program B |
| END OF SESSION 16 | |
| SESSION 17 SCHEDULE | |
|
Tuesday
SESSION 17:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH - PART 1
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 7:00 AM - 7:05 AM | Introduction To The Symposium |
| Presenter(s):Frank J. Veith, MD | |
| 7:05 AM - 7:15 AM | Welcome And Introduction |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism—What Is The Role Of The History, Exam, Biomarkers |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 7:25 AM - 7:35 AM | Do We Need An Echo To Manage Acute Submassive PE |
| Presenter(s):David M. Dudzinski, MD | |
| View Slides in PDF | |
| 7:35 AM - 7:45 AM | Advanced Imaging For PE: What Is The Optimal Strategy For The Diagnosis Of Acute And Chronic PE |
| Presenter(s):Brian B. Ghoshhajra, MD, MBA | |
| View Slides in PDF | |
| 7:45 AM - 8:00 AM | Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember |
| Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
| View Slides in PDF | |
| 8:00 AM - 8:10 AM | Testing For Cancer And Other Hypercoagulable States In PE |
| Presenter(s):Rachel Rosovsky, MD, MPH | |
| View Slides in PDF | |
| 8:10 AM - 8:20 AM | The First Opportunity—The Emergency Physician Algorithm For Acute PE Management |
| Presenter(s):Rachel Rosovsky, MD, MPH / D. Mark Courtney, MD | |
| 8:20 AM - 8:35 AM | Intravenous Thrombolytic Therapy For PE: No Need For Catheter-Based Intervention |
| Presenter(s):Jay Giri, MD, MPH | |
| View Slides in PDF | |
| 8:35 AM - 8:45 AM | Advancing The Science In PE Treatment—What Do We Need To Know, And How Will We Learn |
| Presenter(s):Akhilesh K. Sista, MD | |
| View Slides in PDF | |
| 8:45 AM - 8:55 AM | Ultrasound-Assisted Pharmacomechanical Thrombectomy—Does This Really Work |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 8:55 AM - 9:05 AM | What Device Is Best For Acute PE Intervention |
| Presenter(s):James F. Benenati, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:15 AM | Step-By-Step Technical Tips For Pharmacomechanical Intervention For PE |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 9:15 AM - 9:25 AM | Percutaneous Mechanical Thrombectomy Without Lytics: The Results Of The FLARE Study |
| Presenter(s):Thomas M. Tu, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 9:25 AM - 9:45 AM | Panel Discussion |
| Panelist(s): Gary M. Ansel, MD / James F. Benenati, MD / David M. Dudzinski, MD / Brian B. Ghoshhajra, MD, MBA / Jay Giri, MD, MPH / Raghu Kolluri, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Manish Mehta, MD, MPH / Geno J. Merli, MD, MACP, FHM, FSVM / Rachel Rosovsky, MD, MPH / Akhilesh K. Sista, MD / Thomas M. Tu, MD | |
| 9:45 AM - 10:10 AM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 17 | |
| SESSION 18 SCHEDULE | |
|
Tuesday
SESSION 18:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH – PART 2
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 10:10 AM - 10:20 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 10:20 AM - 10:30 AM | Vortex Strategy For Massive PE |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 10:30 AM - 10:40 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:55 AM | Putting It All Together: What Is The Modern Algorithm For Management Of Massive And Submassive PE |
| Presenter(s):Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 10:55 AM - 11:10 AM | Vena Cava Filters In PE Treatment—Do We Need To Do This, And If So, When |
| Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
| View Slides in PDF | |
| 11:10 AM - 11:25 AM | Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension—Has This Become Mainstream |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:35 AM | The Team Approach To PE Management: The National PERT Consortium |
| Presenter(s):Richard N. Channick, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 11:35 AM - 12:00 PM | Challenging Cases And “PERT” Decisions |
| Panelist(s): Gary M. Ansel, MD / Richard N. Channick, MD / Mark G. Davies, MD / Christopher J. Kwolek, MD, MBA / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Kenneth Rosenfield, MD / Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 12:00 PM - 1:00 PM | Lunch Break - 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) End of Program C-1 |
| END OF SESSION 18 | |
| SESSION 19 SCHEDULE | |
|
Tuesday
SESSION 19:
INTRODUCTION TO VASCULAR MALFORMATIONS
Moderators:Krassi Ivancev, MD, PhD / Fiona Rohlffs, MD
|
|
| x | |
| 1:00 PM - 1:02 PM | Welcome |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| 1:02 PM - 1:07 PM | The International Society for the Study of Vascular Anomalies Classification System for Vascular Malformations |
| Presenter(s):Fiona Rohlffs, MD | |
| View Slides in PDF | |
| 1:08 PM - 1:13 PM | Pediatric Hemangioma And Propranolol Medical Management |
| Presenter(s):Laurence M. Boon, MD, PhD | |
| 1:14 PM - 1:19 PM | The Palliative Role Of Sirolimus In Vascular Malformation Management |
| Presenter(s):Laurence M. Boon, MD, PhD | |
| 1:20 PM - 1:28 PM | Ethanol Sclerotherapy Of Hepatic Venous Malformations |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| View Slides in PDF | |
| 1:29 PM - 1:37 PM | Ethanol Sclerotherapy Of Complex Peripheral Venous And Lymphatic Malformations |
| Presenter(s):Wayne F. Yakes, MD | |
| View Slides in PDF | |
| END OF SESSION 19 | |
| SESSION 20 SCHEDULE | |
|
Tuesday
SESSION 20:
HEAD AND NECK VASCULAR MALFORMATION MANAGEMENT; HIGH-FLOW AVMs MANAGEMENT ISSUES
Moderators:Laurence M. Boon, MD, PhD / Robert L. Vogelzang, MD
|
|
| x | |
| 1:38 PM - 1:46 PM | Endovascular Ethanol Sclerotherapy Of Complex Head & Neck Venous And Lymphatic Malformations |
| Presenter(s):Krassi Ivancev, MD, PhD | |
| View Slides in PDF | |
| 1:47 PM - 1:55 PM | Combined Endovascular And Surgical Management Of Head & Neck Vascular Malformations |
| Presenter(s):Laurence M. Boon, MD, PhD | |
| 1:56 PM - 2:04 PM | Direct Laryngoscopy In The Diagnosis And Treatment Of Vascular Malformations |
| Presenter(s):Edward J. Hepworth, MD | |
| 2:05 PM - 2:13 PM | Curative Endovascular Management Strategies Of Complex/Multiple Head & Neck AVMs |
| Presenter(s):Wayne F. Yakes, MD | |
| View Slides in PDF | |
| HIGH-FLOW AVMs MANAGEMENT ISSUES | |
| Moderator(s): Tarek M.S. Radwan, FRCS / Edward J. Hepworth, MD | |
| 2:14 PM - 2:25 PM | The Yakes AVM Classification System: A Guide To Curative Endovascular Treatment Strategies |
| Presenter(s):Fiona Rohlffs, MD | |
| View Slides in PDF | |
| 2:26 PM - 2:33 PM | Where Is The AVM Nidus |
| Presenter(s):Robert L. Vogelzang, MD | |
| View Slides in PDF | |
| 2:34 PM - 2:41 PM | Complex Capillary-Venous Malformations And Their Endovascular Management |
| Presenter(s):Tarek M.S. Radwan, FRCS | |
| View Slides in PDF | |
| 2:42 PM - 2:49 PM | The Retrograde Vein Approach For Curative Endovascular Treatment Of AVMs |
| Presenter(s):Robert L. Vogelzang, MD | |
| View Slides in PDF | |
| 2:50 PM - 3:00 PM | Endovascular Treatment Of Intraosseous Vascular Malformations |
| Presenter(s):Fiona Rohlffs, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:00 PM | End of Program C-2 |
| END OF SESSION 20 | |
| SESSION 21 SCHEDULE | |
|
Tuesday
SESSION 21:
HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (ALL TALKS ARE 4 ľ MINUTES)
Moderators:Evan C. Lipsitz, MD, MBA / Neal S. Cayne, MD
|
|
| x | |
| 3:00 PM - 3:05 PM | New Performance Goals For SFA Endovascular Treatments: How Good Are Current Devices: From The RAPID Multispecialty Registry |
| Presenter(s):Jack L. Cronenwett, MD | |
| View Slides in PDF | |
| 3:05 PM - 3:10 PM | 12 Commandments For Successful BTK Endovascular Interventions In Patients With Chronic Limb Threatening Ischemia (CLTI) |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 3:10 PM - 3:15 PM | DEBATE: With Extensive Foot Gangrene From CLTI, Multivessel Endo Intervention Is The Best Treatment |
| Presenter(s):Vikram S. Kashyap, MD / Norman Kumins, MD / Mehdi H. Shishehbor, DO, MPH, PhD | |
| View Slides in PDF | |
| 3:15 PM - 3:20 PM | DEBATE: Not So: With Extensive Foot Gangrene From CLTI A Vein Bypass To A Single Good Outflow Artery Is The Best Treatment |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 3:20 PM - 3:25 PM | Optimal Treatment Of Diabetics With CLTI And Extensive Ulceration/Gangrene: When Endo, When Open Bypass: What Is The Best Timing For Foot Debridement |
| Presenter(s):Katariina M. Noronen, MD, PhD | |
| View Slides in PDF | |
| 3:25 PM - 3:30 PM | Panel Discussion |
| 3:30 PM - 3:35 PM | Where Do We Stand With Below The Knee (BTK) Drug Coated Balloons (DCBs): What Is Their Future And What Are Open Questions |
| Presenter(s):Marc Bosiers, MD | |
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | New Devices To Facilitate Lower Extremity Endo Treatments And Crossing Of Chronic Total Occlusions (CTOs): A 4 Fr Catheter With A Retractable Needle – The Go Back Crossing Catheter (Upstream Peripheral) And The Bullfrog Device For Injecting Local Anesthesia In The Artery Wall: How Do They Work |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | Spot Stenting Using Multiple Short Stents For Long SFA/Pop Lesions (Vascuflex Multiloc Device From B. Braun Medical): How Does It Work And Results |
| Presenter(s):Erwin Blessing, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | Drug Delivery In BTK Arteries: Where Does It Stand: Where Is It Going: What Are Some New Drug Delivery Concepts |
| Presenter(s):Dierk Scheinert, MD | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | The Challenge Of Treating Extensively Calcified Lesions In CLTI Patients And How To Overcome The Problem |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 3:55 PM - 4:00 PM | Panel Discussion |
| 4:00 PM - 4:05 PM | DEBATE: An Endo First Approach Is Best For All CLTI Patients And Does Not Burn Bridges If An Open Bypass Is Required Later |
| Presenter(s):D. Christopher Metzger, MD | |
| View Slides in PDF | |
| 4:05 PM - 4:10 PM | DEBATE: Not True: Patient First Is Better: Endo First Does Not Work For All CLTI Patients: Target Arteries For Later Open Bypass Can Be Damaged (Bridges Burned) |
| Presenter(s):Philip P. Goodney, MD, MS | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Long-Term (5 Years) Effectiveness Of Zilver PTX Drug Eluting Stents (DESs) For Fempop In Stent Restenosis (ISR): From The Japanese Post Market Surveillance Study |
| Presenter(s):Kimihiro Komori, MD, PhD | |
| View Slides in PDF | |
| 4:15 PM - 4:20 PM | The “Balloon Wrap” Issue As A Cause Of Dissections With Balloon Angioplasty (PTA): What Is It And Which Balloons Are Least Affected By It |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Update On The Value Of Toe Pressures, Statins And Clopidogrel In CLTI: Why They Matter |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Tuesday
SESSION 22:
MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (ALL TALKS ARE 4 ľ MINUTES)
Moderators:Craig M. Walker, MD / Peter A. Schneider, MD
|
|
| x | |
| 4:30 PM - 4:35 PM | Character And Localization Of Arterial Calcification Pathologically: What Are The Implications For Endo Treatments |
| Presenter(s):Renu Virmani, MD | |
| View Slides in PDF | |
| 4:35 PM - 4:40 PM | Significance Of Calcification In Lower Extremity Arteries Clinically: How To Evaluate It: What Does It Mean For Endo Treatments |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | DESs Versus DCBs: Which Is Best When: Which Is More Cost Effective |
| Presenter(s):Mohammad H. Eslami, MD, MPH | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | DEBATE: When Common Femoral Artery (CFA) Lesions Need Treatment, Open Endarterectomy Is The Procedure Of Choice |
| Presenter(s):Matthew T. Menard, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | DEBATE: Not So: CFA Lesions Are Best Treated By Angioplasty And Stenting: 2-Year Results With The Supera Stent (Vasculomimetic Implant [VMI] From Abbott) |
| Presenter(s):Yann Gouëffic, MD, PhD / Koen R. Deloose, MD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Stenting Of CFA Lesions Compares Favorably To Endarterectomy In A RCT (TECCO Trial) Even When The Distal Bifurcation Is Involved: The Culotte Technique For Stenting Both CFA Branches |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | 2-Year Results Of The ZILVER PASS RCT Comparing Zilver PTX DES Treatment To Open Prosthetic Bypasses For Long Fempop Lesions: Patency Is Equal But Complications And Length Of Stay Less With Zilver PTX |
| Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD | |
| View Slides in PDF | |
| 5:05 PM - 5:10 PM | Distal Bypasses Can Save Limbs With Extensive Gangrene And Calcified Arteries In Dialysis Patients: Key Technical Tips |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 5:10 PM - 5:15 PM | Panel Discussion |
| 5:15 PM - 5:20 PM | 5-Year Follow-Up Outcomes And Lessons Learned From The In.Pact Deep DCB RCT For BTK Lesions: Managing CLTI Patients Is Challenging |
| Presenter(s):Jos C. van den Berg, MD, PhD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Role Of New Stem Cell Therapies In Treating Lower Extremity Ischemia |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | How To Use CO2 As A Contrast Agent To Visualize Patent Foot Arteries In CLTI Patients |
| Presenter(s):Jim Caridi, MD, FSIR | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | Technical Tips For Using CO2 As A Contrast Agent To Image Patent Tibial And Foot Arteries Better And Safely |
| Presenter(s):Palma M. Shaw, MD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | Value Of Adequate Vessel Prep And Duplex Imaging In Optimizing Results Of Balloon And DCB Angioplasty In Crural (Tibial) Arteries – Especially With Long Lesions |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | Nanotechnology: A New Frontier In The Imaging And Treatment Of CLTI |
| Presenter(s):Sean C. Morris, BSci | |
| View Slides in PDF | |
| 5:45 PM - 5:50 PM | Infrainguinal Bypasses After Failed Endovascular Treatments Have Lower Patency And Higher Amputation Rates Than Primary Bypasses |
| Presenter(s):Alik Farber, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | Extensive Heel Gangrene With CLTI Is Not A Contraindication To Limb Salvage: How To Save The Limb In This Setting |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | Panel Discussion End of Program C-3 |
| END OF SESSION 22 | |
|
Wednesday, November 20, 2019
Print Entire 2019 Program:
|
|
| SESSION 23 SCHEDULE | |
|
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
|
|
| x | |
| 6:40 AM - 6:45 AM | Understanding US FDA IDEs (Investigative Device Exemptions) Trials For Evaluating Lower Extremity Endo Devices – Especially BTK Devices: What These Will Tell Us (About Patency) And What They Won’t Tell Us (About Amputation Free Survival) |
| Presenter(s):Patrick J. Geraghty, MD | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Optimal Techniques For Vessel Preparation Before Deployment Of A Drug Coated Or Uncoated Balloon Or Stent |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Value Of IVUS In Lower Extremity Endovascular Treatments: It Is A Management-Altering, Must Have Game Changer |
| Presenter(s):Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Which Wires And Catheters Are Best To Reach Infrainguinal Arteries Via A Radial Approach: Innovative New Wire Engineering Designs To Improve Performance Of 104 Wires: What Is A Twist Wire And How Does It Work |
| Presenter(s):Craig M. Walker, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | Endovascular Treatment Is Appropriate For CLTI Patients With Heel Gangrene Involving The Os Calcis And Achilles Tendon: Limb Salvage With Function Can Be Achieved And How |
| Presenter(s):Iris Baumgartner, MD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | What Is The Future Of Stenting In The Current DCB World: DCBs Do Not Always Work For Complex Lesions: Leave Nothing Behind Is Only A Dream |
| Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD | |
| View Slides in PDF | |
| SOME COMMENTS ON ENDOVASCULAR TREATMENTS OF ARTERIAL LESIONS IN THE FOOT | |
| 7:16 AM - 7:21 AM | How Durable Is The Patency Of Balloon Angioplasty Of Foot Arteries And Plantar Loop Procedures: Why It May Not Matter |
| Presenter(s):Marco G. Manzi, MD | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Should We Treat Foot Vessel Lesions Or Is Such Treatment Fanciful Or Harmful: How Should We Monitor Such Treatment: What Is The End Point And When Is Open Surgery Better |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | Small Artery Disease (SAD) And Medial Artery Calcification (MAC) In The Foot: What Is Its Role In Severe CLTI And How Is It Best Treated |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | Open Bypass To Foot Arteries Can Save Limbs If Foot Arteries And Arches Have Not Been Instrumented: A Note Of Caution |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Role Of Distal Bypass In CLTI With Severe Gangrene: What % Of Such Patients Will Need One At Some Time In Their Course: When Are Pedal Bypasses Better Than Pedal Loop Procedures |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 7:46 AM - 7:52 AM | Panel Discussion |
| END OF SESSION 23 | |
| SESSION 24 SCHEDULE | |
|
Wednesday
SESSION 24:
PROGRESS IN STENT BASED TREATMENTS, ATHERECTOMY AND LITHOPLASTY (LITHOTRIPSY) FOR LOWER EXTREMITY OCCLUSIVE LESIONS
Moderators:Patrick J. Geraghty, MD / Kenneth Rosenfield, MD
|
|
| x | |
| 7:52 AM - 7:57 AM | DCBs Versus DESs: Advantages And Disadvantages Of Each: Why DCBs Should Be First Line Therapy For Most Lesions In Most Patients |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 7:58 AM - 8:03 AM | For Fempop Lesions, Zilver PTX DESs Are Durable Effective Treatment: 5-Year Results Show It Even In Adverse Circumstances: New Findings From The Zilver PTX RCT |
| Presenter(s):Michael D. Dake, MD | |
| View Slides in PDF | |
| 8:04 AM - 8:09 AM | Which Patients With Fempop Occlusive Lesions Are Not Candidates For DCB Treatment: How Should They Be Treated |
| Presenter(s):Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 8:10 AM - 8:15 AM | New Findings From The IMPERIAL RCT Comparing Zilver PTX DESs With Eluvia DESs For Fempop Lesions: Do Differences In Technology And Results In High Risk Subgroups Suggest That Eluvia Is A Better Stent |
| Presenter(s):William A. Gray, MD / Stefan Mueller-Huelsbeck, MD | |
| View Slides in PDF | |
| 8:16 AM - 8:21 AM | Not Sure That IMPERIAL RCT To Date Shows Differences That Are Important: Zilver PTX Is Still A Good DES With Favorable Longer-Term Results And Both Stents Produced Equal Improvement In Symptoms |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 8:22 AM - 8:27 AM | Another View On When To Use Which Stent For Fempop Lesions: Supera, Zilver PTX, Eluvia Or Others |
| Presenter(s):Iris Baumgartner, MD | |
| View Slides in PDF | |
| 8:28 AM - 8:33 AM | Eluvia (Boston Scientific) Is The Only Polymer Based Paclitaxel DES Technology, And It Is Now Being Studied For BTK Lesions In The SAVAL RCT |
| Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD | |
| View Slides in PDF | |
| 8:34 AM - 8:39 AM | Bioresorbable Everolimus DESs For Treating BTK Lesions: The Results With The Absorb Stent (Abbott) Were Favorable For 5 Years: What Does The Future Hold For Such Stents |
| Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD | |
| View Slides in PDF | |
| 8:40 AM - 8:45 AM | Current Status And Improvements In Atherectomy Devices: Which One Or Ones Are Best And Why: For Stand-Alone Treatment Or For Vessel Preparation For Other Treatments |
| Presenter(s):Lawrence A. Garcia, MD | |
| View Slides in PDF | |
| 8:46 AM - 8:51 AM | Which Atherectomy Device Is Best And Why; A European Perspective And Shockwave Based Technology With A Jack-Hammer Effect To Facilitate CTO Wire Crossing (From Soundbite Medical Solutions); How It Works |
| Presenter(s):Marianne Brodmann, MD | |
| View Slides in PDF | |
| 8:52 AM - 8:57 AM | Update On Intravascular Lithotripsy (Lithoplasty) To Treat Calcified Occlusive Lesions: When Is It Worthwhile And When Not: From The DISRUPT PAD Trials And The REAL World Registry |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 8:58 AM - 9:02 AM | Late Breaking 5-Year Results Of Bioresorbable DES (Abbott) For BTK Lesions: Future Implications |
| Presenter(s):Brian G. DeRubertis, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD | |
| View Slides in PDF | |
| 9:02 AM - 9:10 AM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 24 | |
| SESSION 25 SCHEDULE | |
|
Wednesday
SESSION 25:
NEW DEVELOPMENTS IN LOWER EXTREMITY RELATED TOPICS: DOWNSIDE OF DCBs: THE PACLITAXEL COATED DEVICES INCREASE MORTALITY ISSUE
Moderators:Kenneth Ouriel, MD, MBA / Gary M. Ansel, MD
|
|
| x | |
| 9:10 AM - 9:15 AM | Introductory Remarks And Overview |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | The Downsides To DCBs: Cost; Distal Embolization; Increased Mortality: Are They Substantive |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Update On The Meta-Analysis Showing An Increased Mortality In Patients Treated With Drug (Paclitaxel) Coated Lower Extremity Devices (DCBs And DESs): What Is The Current Interpretation |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | Understanding The Pharmacology, Mechanisms Of Action And Toxicity Of Paclitaxel On Drug Coated Devices: How Could Paclitaxel Influence Mortality |
| Presenter(s):Juan F. Granada, MD | |
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Is The Increased Mortality Risk Of Paclitaxel Coated Lower Extremity Devices Observed In The Meta-Analysis Real And Meaningful: Update From The VIVA Leaders Analysis: Currently How Should It Influence Use Of These Devices: Where Is This Issue Going |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | Current Status Of The Discussion On Paclitaxel Coated Lower Extremity Devices And Their Impact On Patient Mortality: Another View And Where Does The FDA Stand And Why |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | What Is The Society for Vascular Surgery (SVS) Doing About This Issue And Where Does It Stand On It |
| Presenter(s):Kim J. Hodgson, MD | |
| View Slides in PDF | |
| 9:52 AM - 9:57 AM | What Is The Response To And Position Of An Industry Partner (Medtronic) Which Is Vested In Drug Eluting Technology |
| Presenter(s):Mark Pacyna | |
| View Slides in PDF | |
| 9:58 AM - 10:03 AM | Update On The Late Results (> 5 Years) Of The Zilver PTX DES Trials That Are Relevant To This Issue: Including The Corrected Late Patient Mortality Data |
| Presenter(s):Michael D. Dake, MD | |
| View Slides in PDF | |
| 10:04 AM - 10:09 AM | Long-Term Safety And Effectiveness Of Paclitaxel Coated Devices Versus Non-Coated Devices For Fempop Occlusive Lesions: From Japanese RCTs And Registries: How Do These Data Bear On The Paclitaxel-Mortality Issue |
| Presenter(s):Osamu Iida, MD / Hiroyoshi Yokoi, MD | |
| View Slides in PDF | |
| 10:10 AM - 10:15 AM | 6-Year Comparison Of Mortality And Its Causes In 1500 Patients Treated With Paclitaxel Coated DCBs Or DESs Versus Bare Metal Stents (BMSs) Or Plain Old Balloon Angioplasty (POBA) |
| Presenter(s):Francesco Liistro, MD | |
| View Slides in PDF | |
| 10:16 AM - 10:19 AM | Large Population Based Multicenter German Study Indicates Paclitaxel Coated Devices May Be Associated With Lower Late Mortality Than Uncoated Devices In Some Patient Subgroups |
| Presenter(s):Christian A. Behrendt, MD | |
| View Slides in PDF | |
| 10:19 AM - 10:25 AM | Panel Discussion |
| END OF SESSION 25 | |
| SESSION 26 SCHEDULE | |
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND OTHER DEVICES FOR TREATING LOWER EXTREMITY OCCLUSIVE LESIONS; RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK TREATMENTS (5- AND 4-MINUTE SHORT SUMMARY [SS] TALKS)
Moderators:Sean P. Lyden, MD / Michael D. Dake, MD
|
|
| x | |
| 10:25 AM - 10:30 AM | Present Status And Future Potential Of DCBs: Is Durability Maintained: Preventing Restenosis And Catch-Up: Importance Of Dual Antiplatelet Agents |
| Presenter(s):Gunnar Tepe, MD | |
| View Slides in PDF | |
| 10:31 AM - 10:36 AM | Best Current Treatment For Long Complex Lesions Is DCBs With Provisional Stenting: What Is The Evidence |
| Presenter(s):John R. Laird, MD | |
| View Slides in PDF | |
| 10:37 AM - 10:42 AM | The REAL PTX RCT Compares DESs Versus DCBs For Treating Fempop Lesions, Some Long And Complex: At 2 Years, Results Are Better With DESs |
| Presenter(s):Andrej Schmidt, MD / Yvonne Bausback, MD | |
| View Slides in PDF | |
| 10:43 AM - 10:48 AM | 5-Year Results From The IN.PACT SFA RCTs Shows Maintained Benefit Of In.Pact DCB Versus POBA For Treatment Of SFA Lesions With No Increase In Complications Or Mortality |
| Presenter(s):Peter A. Schneider, MD / John R. Laird, MD | |
| View Slides in PDF | |
| 10:49 AM - 10:54 AM | The Real World GLOBAL REGISTRY Confirms The Value Of The In.Pact DCB For Treating More Complex SFA Lesions Including In Stent Restenosis (ISR) |
| Presenter(s):Marianne Brodmann, MD / Gary M. Ansel, MD / Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 10:55 AM - 11:00 AM | 2-Year Results Of The COMPARE PILOT RCT Comparing The Ranger DCB (Boston Scientific) With The In.Pact DCB (Medtronic) For Treating Complex Fempop Lesions And 12-Month Results Of Ranger II Trial |
| Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD / Marianne Brodmann, MD | |
| View Slides in PDF | |
| 11:01 AM - 11:06 AM | Safety And Effectiveness Of The Stellarex DCB (Philips) With Low Dose Paclitaxel Up To 3 Years In The Treatment Of Fempop Occlusive Lesions |
| Presenter(s):Fabrizio Fanelli, MD, EBIR / Sean P. Lyden, MD | |
| View Slides in PDF | |
| 11:07 AM - 11:12 AM | Panel Discussion |
| BELOW THE KNEE DCBs | |
| 11:13 AM - 11:18 AM | The ACO ART II RCT Shows Favorable Results With The Orchid DCB To Treat BTK Lesions: With The Right DCB Technology The Future For BTK DCBs Is Brighter Than The Past |
| Presenter(s):Francesco Liistro, MD / Wei Guo, MD | |
| View Slides in PDF | |
| 11:19 AM - 11:24 AM | Results Of A RCT Show The Lutonix DCB (Becton Dickinson/Bard) To Be Better Than POBA For BTK Occlusive Lesions |
| Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Value Of The Stellarex DCB (Philips) For Treating BTK Occlusive Lesions: The ILLUMINATE BTK Trial |
| Presenter(s):Craig M. Walker, MD / Mahmood Razavi, MD | |
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | Update On SurVeil DCBs (Surmodics/Abbott) For Treating BTK Lesions: What Makes This DCB Different: 1-Year Safety And Efficacy From The PreVail Trial |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | Economic Factors In The Treatment Of CLTI: Are Drug Coated Balloons (DCBs) DESs Stents Cost Effective: How Can The Costs Of Devices Be Met |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | What Is The Importance Of Dual Antiplatelet Agents To The Success Of DCBs And What Is The Current Status Of DCBs With Drugs Other Than Paclitaxel |
| Presenter(s):Gunnar Tepe, MD | |
| View Slides in PDF | |
| SHORT SUMMARY 4-MINUTE TALKS | |
| 11:49 AM - 11:53 AM | [SS] Value Of A Scoring Balloon (Ultrascore From Becton Dickinson/Bard) In Vessel Preparation Before DCB Use In Fempop Lesions: How It Works And Experience To Date |
| Presenter(s):Marcus Thieme, MD / Dierk Scheinert, MD | |
| View Slides in PDF | |
| 11:53 AM - 11:57 AM | [SS] DEBATE: SFA Endovascular Treatment Durability Does Not Require Drug Eluting Devices: The Evidence |
| Presenter(s):Lawrence A. Garcia, MD | |
| View Slides in PDF | |
| 11:57 AM - 12:01 PM | [SS] DEBATE: Not So: Drug Elution Is Essential For SFA Endovascular Treatments To Be Effective And Durable |
| Presenter(s):Thomas Zeller, MD / Andrej Schmidt, MD | |
| View Slides in PDF | |
| 12:01 PM - 12:06 PM | Panel Discussion |
| 12:06 PM - 1:00 PM | Lunch Break – 2nd Floor PromenadeVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 26 | |
| SESSION 27 SCHEDULE | |
|
Wednesday
SESSION 27:
EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY OCCLUSIVE DISEASE CAUSING SEVERE CHRONIC LIMB THREATENING ISCHEMIA (CLTI): HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
|
|
| x | |
| 1:00 PM - 1:05 PM | How To Gain Retrograde Arterial Access Via Leg Arteries: The Tibioperoneal Trunk, Peroneal, Posterior Tibial And Anterior Tibial: Equipment And Technical Tips |
| Presenter(s):Miguel F. Montero-Baker, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | ‘Fancy’ Techniques For Getting A Guidewire Across Difficult Chronic Total Occlusions – Especially Those In BTK Arteries In CLTI Patients |
| Presenter(s):Osamu Iida, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | No Option CLTI: The “Desert Foot”: An Increasing Epidemic: An Overview Of Solutions For It And How To Salvage Some Of These Limbs |
| Presenter(s):Marco G. Manzi, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Extreme Distal Lower Limb Revascularization: Durable Solution Or Technical Show Off: Distal Access, Plantar Loop Procedures And Subintimal Angioplasty In Foot Arteries: What Is Their Impact On Mid And Long-Term Results |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR / Michel Rossi, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Treatment Possibilities For “No Option” Patients: Including The Pros And Cons Of Venous Arterialization |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| UPDATE ON VENOUS ARTERIALIZATION | |
| 1:30 PM - 1:35 PM | Surgical Arterialization Of Foot Veins For No Option CLTI: How To Do It And Long-Term Outcomes: From A Pioneer |
| Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Arterialization Of Foot Veins Can Save Limbs With No Option CLTI: How And Why Does It Work And Why Does It Fail: What Is Hybrid Arterialization Of Foot Veins: How Does It Compare To The LimFlow Totally Endo Procedure |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Update On Percutaneous Deep Vein Arterialization (pDVA) With The LimFlow Device For No Option CLTI: Techniques And Results |
| Presenter(s):Steven Kum, MD / Daniel G. Clair, MD / Jihad A. Mustapha, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Panel Discussion |
| 1:53 PM - 1:58 PM | Tibial Bypasses With PTFE Grafts Are Worthwhile (When Autologous Vein Is Lacking) In Hopelessly Threatened Limbs And Can Save A Functional Limb For Many Years: They Deserve A Better Reputation Than They Have |
| Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Neal S. Cayne, MD / Evan C. Lipsitz, MD, MBA / Nicholas J. Gargiulo III, MD, RPVI, RVT, RDMS, FACS / Frank J. Veith, MD | |
| View Slides in PDF | |
| 1:59 PM - 2:04 PM | Ultradistal Bypasses To Below The Ankle Arteries Can Save Limbs With CLTI And Gangrene: How Distal In The Foot Can One Go: No Option CLTI Is Usually A Misnomer |
| Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
| View Slides in PDF | |
| 2:05 PM - 2:10 PM | Extended Open Techniques To Save Threatened Feet When All Endovascular Attempts Have Failed |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 2:11 PM - 2:16 PM | Below The Ankle Angioplasty And Stenting For CLTI: Technical Tips, Indications And Challenges: Poor Patency Rates May Not Hamper Limb Salvage |
| Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
| View Slides in PDF | |
| 2:17 PM - 2:22 PM | Panel Discussion |
| END OF SESSION 27 | |
| SESSION 28 SCHEDULE | |
|
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN LOWER EXTREMITY IN STENT RESTENOSIS (ISR); SELF-EXPANDING STENT-GRAFTS (VIABAHN); HEPARIN BONDING; ARTERIAL CALCIFICATION; UNUSUAL LOWER EXTREMITY STENTS AND THE IMPORTANCE OF HEPARIN BONDING TO PTFE GRAFTS AND DCB INFLATION PRESSURES (SEE ALSO SESSION 59)
Moderators:Richard F. Neville, MD / Neal S. Cayne, MD
|
|
| x | |
| IN STENT RESTENOSIS (ISR) | |
| 2:22 PM - 2:27 PM | Update On Best Current Treatment For In Stent Restenosis (ISR): A European Perspective |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 2:28 PM - 2:33 PM | Update On The Best Current Treatment For ISR Of Varying Grades: A US Perspective |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 2:34 PM - 2:39 PM | A Different View Of Optimal Treatment For Varying Grades Of ISR: When Is A Stent-Graft The Best Treatment |
| Presenter(s):Marc Bosiers, MD | |
| View Slides in PDF | |
| NEW DEVELOPMENTS IN VALUE OF SELF-EXPANDING STENT GRAFTS (VIABAHN) | |
| 2:40 PM - 2:45 PM | Update On Value And Indications Of The Viabahn Self-Expanding Stent-Graft For Fempop Occlusive Disease: Evolution Of The Device: Technical Tips And 5-Year Results From Japan |
| Presenter(s):Osamu Iida, MD | |
| View Slides in PDF | |
| 2:46 PM - 2:51 PM | Value Of Viabahn Stent-Grafts To Treat Failing And Failed Fempop Grafts: Technical Tips And Results |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 2:52 PM - 2:57 PM | Comparison Of Endoluminal Bypass With Viabahn Stent-Grafts Versus Supera Vasculomimetic Stents For Treating Fempop Occlusive Lesions: Indications For And Advantages And Limitations Of Each: When Is An Open Bypass Necessary |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 2:58 PM - 3:03 PM | Panel Discussion |
| PTFE-HEPARIN BONDING | |
| 3:03 PM - 3:08 PM | Comparison Of Heparin Bonded PTFE Grafts To Those Without Heparin Bonding |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| THE DETOUR PROCEDURE | |
| 3:09 PM - 3:14 PM | Percutaneous (PQ) Transvenous Endovascular Fempop Arterial Bypass For Treating Long (30-40 cm) SFA Occlusions: How Does It Work And 2-Year Results: From The DETOUR Trials |
| Presenter(s):Sean P. Lyden, MD | |
| View Slides in PDF | |
| 3:15 PM - 3:20 PM | Will The Detour Procedure For PQ Endovenous Fempop Arterial Bypass Eliminate The Need For Open Surgery: When Will It And When Won’t It |
| Presenter(s):Dainis K. Krievins, MD | |
| View Slides in PDF | |
| ARTERIAL CALCIFICATION | |
| 3:21 PM - 3:26 PM | Types Of Arterial Calcification And How They Impede Balloon Angioplasty Of Occluded Tibial Arteries: How Can It Be Overcome: The DEKIAP (Direct Extravascular Kalcium Interruption Arterial Procedure): Technique And Results |
| Presenter(s):Steven Kum, MD | |
| View Slides in PDF | |
| UNUSUAL LOWER EXTREMITY STENTS | |
| 3:27 PM - 3:32 PM | Initial Experience With A 3 French Compatible Microstent For Antegrade Or Retrograde Treatment Of Tibial Artery Lesions (From Micro Medical Solutions) |
| Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
| View Slides in PDF | |
| 3:33 PM - 3:38 PM | 2-Year Results With The 3D Helical Stent That Induces Swirling Flow: The MIMICS-2 Trial Shows This Stent Works Well For Complex SFA Lesions (From Veryan Medical) |
| Presenter(s):Timothy M. Sullivan, MD / Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| 3:39 PM - 3:50 PM | Panel Discussion |
| 3:50 PM - 4:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 28 | |
| SESSION 29 SCHEDULE | |
|
Wednesday
SESSION 29:
UPDATES ON LOWER EXTREMITY CLTI GUIDELINES, RCTs AND FOOT PERFUSION INDICATORS
Moderators:Joseph L. Mills, MD / Thomas Zeller, MD
|
|
| x | |
| 4:00 PM - 4:10 PM | What Is New And Good About The Recent Multispecialty Global Vascular Guidelines For CLTI: What Are Their Limitations And Why Is TASC Outdated |
| Presenter(s):Michael S. Conte, MD / Andrew W. Bradbury, MD, FRCSEd / Philippe Kolh, MD | |
| View Slides in PDF | |
| 4:11 PM - 4:16 PM | Update On The BASIL 2 And 3 RCTs: 2 Compares Crural Vein Bypasses With Endovascular Treatments; 3 Compares DCBs And DESs With POBA And Uncoated Stents |
| Presenter(s):Andrew W. Bradbury, MD, FRCSEd | |
| View Slides in PDF | |
| 4:17 PM - 4:22 PM | DEBATE: Progress In The BEST-CLI RCT Comparing Open And Endo Treatments: This Trial Will Provide Important New Information On The Best Treatment For CLTI |
| Presenter(s):Alik Farber, MD / Matthew T. Menard, MD / Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 4:23 PM - 4:28 PM | DEBATE: Sorry, BEST-CLI Does Not Reflect Real World Practice And Will Have Little Value In Guiding Best Treatment For CLTI Which Must Be Individualized |
| Presenter(s):George L. Adams, MD / Miguel F. Montero-Baker, MD | |
| View Slides in PDF | |
| 4:29 PM - 4:34 PM | The SPINACH Registry Shows That Open Bypass Is Better In CLTI With Extensive Gangrene: On The Other Hand, Endo First Is Better In High Risk Patients |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 4:35 PM - 4:40 PM | How To Evaluate Below The Ankle Arteries And Occlusions: CTA And Standard Arteriography Is Inadequate And Some Patent Arteries Will Not Be Seen; Need Distal Interventional Arteriography: How To Do It |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 4:41 PM - 4:46 PM | Surgery Guided Revascularization And Flow Guided Surgery: What Do They Mean And Why They Are Important To Saving Limbs: Optimal Timing And Type Of Surgery For Gangrene In CLTI: How To Get A Functional Limb |
| Presenter(s):Giacomo Clerici, MD / Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 4:47 PM - 4:52 PM | How To Optimize Endovascular Treatment To Achieve Adequate Foot Perfusion To Heal Foot Wounds In CLTI: How To Measure It; What Are The Variables |
| Presenter(s):Vikram S. Kashyap, MD / Mehdi H. Shishehbor, DO, MPH, PhD | |
| View Slides in PDF | |
| 4:53 PM - 4:58 PM | Indocyanine Green Fluorescence (ICG-FL) Is The Best Way To Measure Foot Perfusion After Revascularization: Open Bypass Does Better Than Endo: Why The Angiosome Concept Is More Important After Endo Than Open Procedures |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 4:59 PM - 5:04 PM | Pedal Temperature Measurements After Revascularization Will Indicate Healing Potential And Optimal Time For Foot Surgery: How To Standardize These Measurements And Make Them Valid |
| Presenter(s):Wayne J. Caputo, DPM | |
| View Slides in PDF | |
| 5:05 PM - 5:11 PM | Panel Discussion |
| END OF SESSION 29 | |
| SESSION 30 SCHEDULE | |
|
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Moderators:Michael S. Conte, MD / Neal S. Cayne, MD
|
|
| x | |
| INTERMITTENT CLAUDICATION (IC) | |
| 5:11 PM - 5:16 PM | In Patients With IC From SFA Lesions, Stenting Plus Best Medical Treatment (BMT) Improved Quality Of Life And ABI More Than BMT Alone For 2 Years In An RCT |
| Presenter(s):Hans Lindgren, MD, PhD | |
| View Slides in PDF | |
| 5:17 PM - 5:22 PM | Why Most Patients With IC Due To SFA Lesions Should Not Undergo Stenting |
| Presenter(s):Neal S. Cayne, MD | |
| View Slides in PDF | |
| 5:23 PM - 5:28 PM | Endovascular Treatments For IC Can Lead To CLTI And Burn Bridges: Causes And Remedies |
| Presenter(s):Niten Singh, MD | |
| View Slides in PDF | |
| ACUTE LIMB ISCHEMIA (ALI) | |
| 5:29 PM - 5:34 PM | Update On Newer Endovascular Thrombosuction Devices For ALI: When Is Open Treatment Required |
| Presenter(s):Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | Thrombolysis For ALI: Is Its Use Increasing Or Decreasing: Tips In Its Use To Make It Safer By Coupling It With Mechanical Thrombectomy Devices |
| Presenter(s):Marcus Thieme, MD | |
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | Mechanical Endothrombectomy Is Eliminating The Need For Lytic Agents And Making The Treatment Of ALI Safer |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | DEBATE: All Patients With ALI Can And Should Be Treated Endovascularly |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 5:53 PM - 5:58 PM | DEBATE: Not So: Some Patients With ALI Require Open Treatment: Which Ones And Why: Technical Tips |
| Presenter(s):Joseph L. Mills, MD | |
| View Slides in PDF | |
| 5:59 PM - 6:04 PM | New Findings In The Treatment Of ALI: From The Recently Updated European Guidelines: Paradigms Are Changing |
| Presenter(s):Martin Bjorck, MD, PhD | |
| View Slides in PDF | |
| 6:05 PM - 6:10 PM | Aspiration Thrombectomy For ALI Due To Thrombosed Popliteal Aneurysms: A Better Way To Treat: Technical Tips And Results |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 6:11 PM - 6:20 PM | Panel Discussion End of Program D |
| END OF SESSION 30 | |
| SESSION 31 SCHEDULE | |
|
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, ANTI-ATHEROGENIC DRUGS AND CARDIAC AND CORONARY ARTERY RISK EVALUATION IN PATIENTS WITH VASCULAR DISEASE
Moderators:Ido Weinberg, MD, MSc / Caron B. Rockman, MD
|
|
| x | |
| 6:40 AM - 6:45 AM | What Is Currently The Best Way To Assess Cardiac Risk In Open Vascular Surgery Patients; In Endovascular Treatment Patients |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | Fractional Flow Reserve From Coronary CT (FFRCT): What Is It, And It Is A Better Way To Guide Coronary Artery Revascularization |
| Presenter(s):Gregg W. Stone, MD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Value Of Non-Invasive FFRCT In Decreasing Cardiac Complications In Patients Undergoing Lower Extremity Revascularization (Bypasses) And CEAs: It Allows High Risk Asymptomatic Patients To Be Detected Proactively And Treat Better |
| Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | Improvements In And What Is Coming In Medical Treatment To Prevent Death And Complications From Arteriosclerosis: Update On PCSK-9 Inhibitors Including Inclisiran, Ezetembe, Anti-Inflammatory Drugs And Treating High Lp(a) Levels |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | DEBATE: Adherence To Statin Therapy With Attention To Increase Dosage Of High Potency Statins (Atorvastatin And Ruvostatin) Boosts Survival And Is Valuable In The Elderly (> 75): Adverse Effects Are Rare |
| Presenter(s):Richard Bulbulia, MA MD FRCS | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | DEBATE: Statins Are Not A Miracle Drug And Have Been Overvalued: They Have Unrecognized Harmful Effects As Does Excessive Lowering Of LDL Cholesterol (LDL-C): Have We Been Misled And By Whom |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Highlights Of The New AHA Guidelines For Management Of Cholesterol Levels: What LDL-C Levels Should We Strive For In Our Vascular Patients: Why Are Non-HDL Levels A Better Indicator Of Atherosclerotic Risk Than LDL-C Levels |
| Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Value Of Lipid Lowering For Treating Plaques In Coronary And Other Arteries: Best Drug Combination And Benefit Of PCSK-9 Inhibitors: How Low Should LDL-C Be Driven: Can Plaques Be Made Smaller And Less Dangerous |
| Presenter(s):Ron Waksman, MD | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | Current Value Of Antithrombotic And Antiplatelet Therapy In Vascular Patients: What Drugs Should They Be On – When And Why: The COMPASS RCT Shows That Low Dose Rivaroxaban And Aspirin Decreases Death, Stroke And MI In Vascular Patients: What About Aspirin Alone |
| Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | How To Detect Vulnerable Plaque (Lipid Rich Plaque [LRP]) And Mortality Risk With New Infrared Spectroscopy (NIRS); How Does It Work: What Can Be Done About LRPs |
| Presenter(s):Ron Waksman, MD | |
| View Slides in PDF | |
| 7:40 AM - 7:47 AM | Panel Discussion |
| END OF SESSION 31 | |
| SESSION 32 SCHEDULE | |
|
Wednesday
SESSION 32:
MORE ADVANCES IN MEDICAL TREATMENTS; MORE ABOUT NEW DRUGS; STEM CELL TREATMENTS; CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION
Moderators:Michael R. Jaff, DO / Kim J. Hodgson, MD
|
|
| x | |
| MORE ABOUT NEW DRUG TREATMENTS | |
| 7:47 AM - 7:52 AM | New RCT Evidence Shows That An Omega 3 Fatty Acid Formula, Vascepa, Reduces By 25% Major Adverse Cardiac Events In Patients With High Triglycerides (The REDUCE-IT Trial): Bempedoic Acid Reduces LDL-C And C-Reactive Protein: Improved Best Medical Treatment Will Sharply Decrease The Need For Interventional Treatments |
| Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
| View Slides in PDF | |
| 7:53 AM - 7:58 AM | Optimal Use Of Direct Oral Anticoagulants (DOACs) After Open Bypasses And After Endovascular Procedures |
| Presenter(s):Peter Henke, MD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | All Vascular Patients Should Be On Statins: What Drug, What Dose: It Matters: There Are Dire Penalties If Statins Are Stopped |
| Presenter(s):Christos D. Liapis, MD | |
| View Slides in PDF | |
| UPDATE ON STEM CELL THERAPY | |
| 8:05 AM - 8:10 AM | Does Stem Cell Therapy Have A Future In The Treatment Of Ischemic Vascular Disease |
| Presenter(s):Dong-ik Kim, MD | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Update On The Value Of Autologous Stem Cell Therapy To Treat Lower Extremity Ischemia: Many Studies Indicate It Helps, But Not Much |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| ADVANCES IN CATHETER BASED TREATMENT OF RESISTANT HYPERTENSION | |
| 8:17 AM - 8:22 AM | Current Status And Future Potential Of Endovascular Devices In The Treatment Of Resistant Hypertension: Does Renal Denervation Work |
| Presenter(s):Sahil A. Parikh, MD | |
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Status Of RCTs And Other Trials Showing The Comparative Value Of Different Catheter Based Techniques For Renal Denervation For Alleviating Resistant Hypertension: Radiofrequency (Spyral – Medtronic), Ultrasound Paradise Catheter (ReCor Medical), And Alcohol Infusion Into Renal Artery Adventitia (Peregrine Catheter, Ablative Solutions); They All Work |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | Value Of A Stent-Like Mobius HD Device (From Vascular Dynamics) To Reshape The Carotid Sinus, Amplify The Baroreflex And Lower Blood Pressure In Drug Resistant Hypertension |
| Presenter(s):Gregg W. Stone, MD / Kim J. Hodgson, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | Update On Value Of ROX Coupler Device To Create An Iliac A-V Fistula And Control Blood Pressure In Resistant Hypertension: How It Works And Results Of A Sham Controlled RCT |
| Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | Late Breaking Results Cast Doubt On The Katsanos Meta-Analysis: A Multicenter Study In 2071 Propensity Matched Patients (With CTLI And IC) Shows No Mortality Effect Of Paclitaxel Coated Devices 2 Years After Treatment |
| Presenter(s):Hany Zayed, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:54 AM | Panel Discussion |
| 8:54 AM - 9:04 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| SESSION 33 SCHEDULE | |
|
Wednesday
SESSION 33:
PROGRESS IN MANAGING COMPLICATIONS AND ENDOLEAKS AFTER EVAR AND TEVAR
Moderators:Juan C. Parodi, MD / Michel Makaroun, MD
|
|
| x | |
| 9:04 AM - 9:09 AM | Total Aortic Occlusion With Worsening Visceral And Renal Ischemia After TEVAR For Acute TBAD Can Be Due To Complete Dissection Flap Detachment And Distal Migration: Causes And Diagnosis: Urgent Open Flap Excision Is Life-Saving |
| Presenter(s):Mark K. Eskandari, MD / Heron E. Rodriguez, MD | |
| View Slides in PDF | |
| 9:10 AM - 9:15 AM | Major Trauma Can Lead To High Flow Endoleaks In EVAR Patients: What Is The Mechanism: What Is The Best Treatment |
| Presenter(s):Carlo Setacci, MD | |
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | Endoleaks After TEVAR: Incidence, Nature, Etiology, Diagnosis And Treatment |
| Presenter(s):Maciej L. Dryjski, MD, PhD | |
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Natural History Of Type 2 Endoleaks With And Without Treatment: From A 1000 Patient Study |
| Presenter(s):Carlo Pratesi, MD / Raffaele Pulli, MD | |
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | Little Known Facts About Endoleaks After EVAR: Natural History Of Late Type 1 Endoleaks Is Not Benign – Urgent Treatment Is Required: An Enlarging AAA Sac With A Type 2 Endoleak Usually Indicates The Presence Of An Associated Type 1 Endoleak |
| Presenter(s):O. William Brown, MD, JD | |
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Value Of CT Fusion Guidance And Liquid Embolic Agents To Treat Type 2 Endoleaks: Technical Tips And How To Do It With The Best Chance Of Success |
| Presenter(s):Neal S. Cayne, MD | |
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | How Common Are Failures Of Interventions For Type 2 Endoleaks: What Are The Reasons And When Is Open Treatment Indicated: What Should That Open Treatment Be |
| Presenter(s):Ronald M. Fairman, MD | |
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | Minimizing Type 2 Endoleaks With Careful Imaging And Pre-EVAR Side Branch Coiling: It Works: Technical Tips |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 9:52 AM - 9:59 AM | Panel Discussion |
| 9:59 AM - 10:04 AM | Transgraft Access And Onyx Embolization For Type 2 Endoleaks Difficult To Approach And Treat: Technique And Results |
| Presenter(s):Mark W. Mewissen, MD, RVT | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Optimal Strategy For And Results Of Treating Type 2 Endoleaks: It Is Not Simple |
| Presenter(s):Sonia Ronchey, MD, PhD | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Role Of Anticoagulation And Endogenous Thrombolysis In The Occurrence And Resolution Of Late Type 2 Endoleaks: How Should They Influence Treatment |
| Presenter(s):Natzi Sakalihasan, MD, PhD | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Value Of Fibrin Glue Sac Filling With EVAR To Prevent Type 2 Endoleaks: Technique, Value And Limitations |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | Sac Access Routes To Treat Type 2 Endoleaks: Techniques, Advantages And Limitations Of Each |
| Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
| View Slides in PDF | |
| 10:29 AM - 10:34 AM | Treating Type 2 Endoleaks By A Paragraft Approach: Indications, Technique And Results |
| Presenter(s):Peter A. Schneider, MD | |
| View Slides in PDF | |
| 10:35 AM - 10:40 AM | How Does Endograft Covering Material (Polyester vs. PTFE) Influence Type 2 Endoleak Rates And Behavior After EVAR |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | Value Of Liquid Embolic Agents And Onyx In Treating Type 1 And Type 2 Endoleaks: Technical Tips And Results |
| Presenter(s):Robert A. Morgan, MD | |
| View Slides in PDF | |
| 10:47 AM - 10:52 AM | Importance Of Recognizing Visceral Artery Occlusive Disease Before Performing EVAR: How To Diagnose And Treat |
| Presenter(s):Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD | |
| View Slides in PDF | |
| 10:53 AM - 11:00 AM | Panel Discussion |
| END OF SESSION 33 | |
| SESSION 34 SCHEDULE | |
|
Wednesday
SESSION 34:
RECORDED LIVE CHALLENGING AND COMPLEX CASES FROM LINC AND LEIPZIG
|
|
| x | |
| 11:00 AM - 11:20 AM | Vessel Preparation By Mechanical Debulking Using The Rotarex Atherectomy System; Including Recorded Case Presentation |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 11:20 AM - 11:40 AM | Minimally Invasive Solutions For Challenging Peripheral Occlusions: The PQ-Bypass Technique; Including Recorded Case Presentation |
| Presenter(s):Mark A. Adelman, MD | |
| View Slides in PDF | |
| 11:40 AM - 11:50 PM | Optimizing Results Of BTK Procedures: Latest Data On BTK DCB From The AcoARt BTK Study And Optimization Of Recanalization Results With Tack BTK Scaffolds; Including Recorded Case Presentation |
| Presenter(s):Dierk Scheinert, MD | |
| View Slides in PDF | |
| 11:50 AM - 12:00 PM | DCB And Tack Treatment Of BTK CTOs |
| Presenter(s):Andrej Schmidt, MD | |
| 12:00 PM - 12:50 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 34 | |
| SESSION 35 SCHEDULE | |
|
Wednesday
SESSION 35:
CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
|
|
| x | |
| 12:50 PM - 12:57 PM | When Is A Technically Successful Arterialization Of The Foot Veins Effective In Preventing Amputation In No-Option CLI Patients |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 12:57 PM - 12:59 PM | Discussion |
| 12:59 PM - 1:06 PM | Open Surgery For Infra- And Juxtrarenal AAA In The Endovascular Era |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:08 PM | Discussion |
| 1:08 PM - 1:15 PM | Unexpected Initial And Final Completion Angiogram For A First In Human Fenestrated Endograf |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 1:15 PM - 1:17 PM | Discussion |
| 1:17 PM - 1:24 PM | Single Session Venous Thrombectomy For Acute Ilio-Femoral Deep Vein Thrombosis: The Advantages Of ZERO Thrombolysis |
| Presenter(s):Gerard J. O'Sullivan, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:26 PM | Discussion |
| 1:26 PM - 1:33 PM | Most Successful Tools For Complex Femoropopliteal CTO Recanalizations |
| Presenter(s):Andrej Schmidt, MD | |
| View Slides in PDF | |
| 1:33 PM - 1:35 PM | Discussion |
| 1:35 PM - 1:42 PM | Endovascular Management Of Complex Fem-Pop And Below Lesions In 2019 |
| Presenter(s):Lorenzo Patrone, MD / Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 1:42 PM - 1:44 PM | Discussion |
| 1:44 PM - 1:51 PM | Vessel Preparation – Is It Relevant In The Tibial Arteries |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 1:51 PM - 1:53 PM | Discussion |
| 1:53 PM - 1:59 PM | Panel Discussion |
| END OF SESSION 35 | |
| SESSION 36 SCHEDULE | |
|
Wednesday
SESSION 36:
TRIBUTE TO A VALUED PARTNER; IMPORTANT ISSUES RELATED TO VASCULAR PRACTICE AND VASCULAR SURGEONS
Moderators:Michael L. Marin, MD / Ronald L. Dalman, MD
|
|
| x | |
| 2:00 PM - 2:05 PM | A Tribute To Sushil K. Gupta, MD, MBA (1949-2019) – A Creative And Talented Surgeon, A Brilliant Innovator And A Treasured Colleague And Friend |
| Presenter(s):Larry A. Scher, MD | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Trials And RCTs Versus Registries: Advantages And Disadvantages Of Each: How Can We Reach The Truth |
| Presenter(s):Charles C. Miller, PhD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Keys To A Successful Career In Vascular Surgery |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | How Vascular Surgeons Can Develop Leadership Skills |
| Presenter(s):Robert B. McLafferty, MD, MBA | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | How Women Vascular Surgeons Look Differently At Gender Differences In Procedural Results Than Their Male Counterparts And Why This Is Advantageous For Female Patients |
| Presenter(s):Rebeca Reachi Lugo, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | How To Teach Competent Open Surgery In The Endovascular Era |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Vascular Surgery Burnout: Why It Occurs: Is It Related To Occupational Or Ergonomic Ailments And Pain: What Can Be Done To Prevent And Fix The Problem |
| Presenter(s):Samuel R. Money, MD, MBA | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | What Constitutes Futility In Our Present Health Care System: When Is Enough Too Much |
| Presenter(s):James W. Jones, MD, PhD, MHA | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Panel Discussion |
| 2:53 PM - 2:58 PM | Lessons Learned By A Creative Physician-Inventor: How To Avoid The Pitfalls In Bringing An Idea To Fruition Without Losing Your Idea Or Your Shirt |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 2:59 PM - 3:04 PM | How Are Silicon Valley Giants And Entrepreneurs Planning To Disrupt Health Care: Will It Improve Things For Patients; For Doctors; For Vascular Specialists |
| Presenter(s):Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 3:05 PM - 3:10 PM | Screening For Vascular Diseases Can Cause More Harm Than Benefit: How To Avoid This Problem |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Variations Around The World In The Treatment Of AAAs And Carotid Stenosis Patients: What Are The Implications: From The Consortium Of Vascular Registries |
| Presenter(s):Jack L. Cronenwett, MD | |
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | Are There Problems With The Appropriateness Of Invasive Treatment By Vascular Surgeons, By Other Vascular Specialists |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | The Hospital Readmission Reduction Program And Its Incentives Have Led To Increased Morbidity And Mortality For Vascular Patients: How Can It Be Fixed To Make It Safe |
| Presenter(s):Philip P. Goodney, MD, MS / Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 3:29 PM - 3:34 PM | What Is The Impact Of The New AAA DRGs On Hospital Reimbursement: Does More Have To Be Done |
| Presenter(s):W. Charles Sternbergh III, MD | |
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | Panel Discussion |
| 3:40 PM - 3:48 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 36 | |
| SESSION 37 SCHEDULE | |
|
Wednesday
SESSION 37:
ISSUES RELATED TO VASCULAR OUTPATIENT CENTERS, OFFICE BASED LABS AND MEDICAL ETHICS
Moderators:Enrico Ascher, MD / Glenn Jacobowitz, MD
|
|
| x | |
| 3:48 PM - 3:53 PM | Why Outpatient Centers And Office Based Labs (OBLs) Are The Best Place To Do Which Endovascular Procedures: Best For Patients And Best For Operators: When Can Atherectomies Be Performed Safely There; When Not |
| Presenter(s):Krishna Jain, MD | |
| View Slides in PDF | |
| 3:54 PM - 3:59 PM | Real World Results Of Lower Extremity Atherectomy (Mostly In Outpatient Centers) From Medicare Billing Data Is Much Worse Than Favorable Registry Data: Where Lies The Truth |
| Presenter(s):Dipankar Mukherjee, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | How To Avoid Unethical Practices In An Outpatient Center Or Office Based Lab (OBL): The Temptation And Incentives To Overtreat Is Great |
| Presenter(s):Stephen M. Bauer, MD | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | Characteristics Of Physicians Who Are Suited To Work In An OBL And Characteristics Of Those Who Are Not |
| Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | Office Based Versus Hospital Based Vascular Care: Impact On Indications, Physician Income And Overall Costs |
| Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | Another View Of The Impact Of Office Based Vascular Practice Patterns On Indications, Physician Incomes And Outcomes |
| Presenter(s):Matthew W. Mell, MD, MS | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | A Propensity Matched Comparison Of Paclitaxel Coated DCBs Versus POBA In Patients With Intermittent Claudication: 5-Year Results Show No Increased Mortality Signal For DCBs |
| Presenter(s):Georgios A. Pitoulias, MD, PhD / Konstantinos P. Donas, MD | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Vascular Screening Is Often Unnecessary, Possibly Harmful And Largely Driven By Financial Gain: When Is It Justified And Beneficial To Patients |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | Advantages To A Vascular Practice Of Having A Wound Care Center |
| Presenter(s):Venita Chandra, MD | |
| View Slides in PDF | |
| 4:42 PM - 4:47 PM | Benefits To A Vascular Practice And Hospital Of Having A Limb Salvage Program: How To Set One Up And Make It Work |
| Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS | |
| View Slides in PDF | |
| 4:48 PM - 4:55 PM | Panel Discussion |
| END OF SESSION 37 | |
| SESSION 38 SCHEDULE | |
|
Wednesday
SESSION 38:
TOPICS RELATED TO THE FDA, VALUE OF A VASCULAR SURGEON, VASCULAR PRACTICE, THE SVS, VQI AND GOVERNMENTAL REGULATIONS AND REIMBURSEMENT
Moderators:Ali F. AbuRahma, MD / Keith D. Calligaro, MD
|
|
| x | |
| 4:55 PM - 5:00 PM | How Innovative Vascular Devices Can Get To Market: What Is The De Novo Pathway |
| Presenter(s):Dorothy B. Abel, BSBME | |
| View Slides in PDF | |
| 5:01 PM - 5:06 PM | What Is The Value Of A Vascular Surgeon To A Health Care System In And Out Of The Operating Room: In Many Ways It Is Priceless But Under-Rewarded |
| Presenter(s):Richard J. Powell, MD / Fred A. Weaver, MD, MMM | |
| View Slides in PDF | |
| 5:07 PM - 5:12 PM | How Can Vascular Surgeons Best Cope In A MIPS And MACRA World: What Will Happen With The Medical Device Excise Tax In 2020 And Why Its Repeal Is Important To Vascular Surgeons And Vascular Specialists |
| Presenter(s):Robert M. Zwolak, MD, PhD | |
| View Slides in PDF | |
| 5:13 PM - 5:18 PM | What Is On The Horizon For Vascular Surgeons And Vascular Specialists Reimbursement: Will Income Go Up Or Down For The Same Amount Of Work |
| Presenter(s):Sean P. Roddy, MD | |
| View Slides in PDF | |
| 5:19 PM - 5:24 PM | Opposite Trends In Reimbursement By CMS For Arterial And Venous Procedures: Implications For Vascular Surgery Practices |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Slides in PDF | |
| 5:25 PM - 5:30 PM | Revascularization For CLTI By Endovascular Treatments Or Open Surgery Is Cost Effective And Saves Lives Compared To Major Amputations |
| Presenter(s):Richard F. Neville, MD / Jihad A. Mustapha, MD | |
| View Slides in PDF | |
| 5:31 PM - 5:36 PM | How To Shorten Lengths Of Stay After Vascular Open Surgery Or Interventions: It Is Not Easy, But It Is Doable |
| Presenter(s):Fred A. Weaver, MD, MMM | |
| View Slides in PDF | |
| 5:37 PM - 5:42 PM | Progress In And Value Of The SVS VQI Program: Where Is It Going And Why Will It Become Increasingly Important |
| Presenter(s):Jack L. Cronenwett, MD | |
| View Slides in PDF | |
| 5:43 PM - 5:48 PM | Improvements In Vascular Specialist, The SVS Newspaper: Opportunities And Challenges And How It Can Benefit Vascular Surgeons And Others |
| Presenter(s):Malachi Sheahan, MD | |
| View Slides in PDF | |
| 5:49 PM - 5:54 PM | Recent Improvements In The JVS: How To Get A Paper Accepted In The JVS: How Best To Review A Paper For The JVS |
| Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 5:55 PM - 6:02 PM | Panel Discussion End of Program E |
| END OF SESSION 38 | |
| SESSION 39 SCHEDULE | |
|
Wednesday
SESSION 39:
MORE TOPICS RELATED TO NEW DEVELOPMENTS IN TREATING AORTIC DISSECTIONS AND ITS COMPLICATIONS
Moderators:Ramon Berguer, MD, PhD / Zhong Chen, MD
|
|
| x | |
| 6:40 AM - 6:45 AM | Retrograde SMA Stenting May Be The Best Way To Treat Mesenteric Compromise From Malperfusion With Aortic Dissections: How To Do It And Results |
| Presenter(s):Dipankar Mukherjee, MD | |
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | When Can The Celiac Trunk Orifice Be Covered Safely During TEVAR And When Not: From A New Meta-Analysis |
| Presenter(s):Wayne W. Zhang, MD | |
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Left Subclavian Revascularization During Zone 2 TEVARs: Comparison Of Open Surgical Bypass Versus Endovascular Revascularization With Parallel Grafts (Chimney Or Periscope) |
| Presenter(s):Giovanni Pratesi, MD | |
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | When Should False Lumen Thrombosing Techniques Be Used In Patients With TBADs: How Best To Do It |
| Presenter(s):Thomas L. Forbes, MD / Cherrie Z. Abraham, MD | |
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | New Technique For False Lumen Occlusion In Chronic Aortic Dissections: Using A Physician Modified Device: How To Do It And Results |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | New Proximal And Distal Re-Entry Tears After TEVAR: What Are The Causative Mechanisms, Risk Factors And Treatments |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | Another View On Endograft Induced Distal Re-Entry Tears After TEVAR: Strategies To Prevent, Diagnose And Treat |
| Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD | |
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | Best Treatment Options For Aortic Dissections In Patients With Connective Tissue Disorders: When Endo; When Open; When Hybrid |
| Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | EVAR And TEVAR Can Work Surprisingly Well In Some Aneurysm Patients With Connective Tissue Disorders; When And When Not: Technical Tips |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | With TBADs, What Are The Flow/Pressure Dynamics That Explain Why TEVAR Can Make Things Worse |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 7:40 AM - 7:45 AM | Advantages To Hybrid Approaches To Complex Aortic And Aortovisceral Artery Pathology: Indications And Technical Tips |
| Presenter(s):William J. Quinones-Baldrich, MD | |
| View Slides in PDF | |
| 7:46 AM - 7:54 AM | Panel Discussion |
| END OF SESSION 39 | |
| SESSION 40 SCHEDULE | |
|
Wednesday
SESSION 40:
MORE NEW DEVELOPMENTS RELATED TO THE ASCENDING AORTA, AORTIC ARCH, F/B/TEVAR AND PARALLEL GRAFTS FOR TREATMENT OF LESIONS IN OR NEAR THE AORTIC ARCH
Moderators:Rodney A. White, MD / Ali Khoynezhad, MD, PhD
|
|
| x | |
| 7:54 AM - 7:59 AM | Wrapping Of The Dilated Ascending Aorta To Avoid More Complex Procedures And Facilitate Placement Of Grafts To Arch Branches: Indications, Contraindications, Technical Tips And Results |
| Presenter(s):Mario L. Lachat, MD / Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 8:00 AM - 8:05 AM | Variations In The Morphology Of Proximal Entry Tears In TBADs: Importance Of These Variations And How Should They Influence Treatment |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | Significance Of Aortic Arch Anomalies: What Are They Associated With: When Do They Require Treatment: What Is The Best Current Treatment |
| Presenter(s):Erik E. Debing, MD, PhD | |
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | What Do Fluid Dynamics Tell Us About The Durability And Long-Term Results Of Aortic Arch Branch And Fenestrated Endografts |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | 3-Branch Endograft For Aortic Arch Aneurysm Repair (From Terumo Aortic): Advantages, Limitations And Results To Date |
| Presenter(s):W. Anthony Lee, MD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | Unusual Branched Endograft Solutions For Aortic Arch Lesions When Industry-Made Commercial Devices Are Unavailable Or Unsuitable |
| Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | How Best To Treat TBADs Extending Into The Arch And Ascending Aorta |
| Presenter(s):I-Hui Wu, MD, PhD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | Value Of Chimney TEVAR (Ch/TEVAR) To Treat Elective And Ruptured Aneurysms Involving The Aortic Arch: A 15-Year Experience And Results |
| Presenter(s):Thomas Larzon, MD, PhD / Tal M. Hörer, MD, PhD | |
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Ch/TEVAR In The Aortic Arch If Done Right Is As Good As F/B/TEVAR And Safer Than Open Surgery: Technical Tips And Results |
| Presenter(s):Armando C. Lobato, MD, PhD / Jan S. Brunkwall, MD, PhD | |
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | Update On Sandwich Grafts For Zone 0 Aortic Arch Lesions: 8-Year Results And Technical Tips |
| Presenter(s):Armando C. Lobato, MD, PhD | |
| View Slides in PDF | |
| 8:54 AM - 9:02 AM | Panel Discussion |
| END OF SESSION 40 | |
| SESSION 41 SCHEDULE | |
|
Wednesday
SESSION 41:
MORE ABOUT JUXTA- AND PARARENAL AAAs, TAAAs, F/B/EVAR AND PARALLEL GRAFTS (CHIMNEY EVAR [Ch/EVAR])
Moderators:Matthew J. Eagleton, MD / Giovanni Torsello, MD
|
|
| x | |
| 9:02 AM - 9:07 AM | A New And Better Way To Define And Classify AAA Neck Anatomy And Indicate Best Treatment |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | For Juxta- And Pararenal AAAs Ch/EVAR Can Yield Dependably Good And Durable Results If Certain Technical Requirements Are Followed And Certain Device Combinations Are Used: Results From The ENCHANT Registry |
| Presenter(s):Giovanni Torsello, MD / Konstantinos P. Donas, MD | |
| View Slides in PDF | |
| 9:14 AM - 9:19 AM | Ch/EVAR For Juxta And Pararenal AAA: Technical Tips To Assure Good Long-Term Results: A 9-Year Experience |
| Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD | |
| View Slides in PDF | |
| 9:20 AM - 9:25 AM | Indications For Chimney And Sandwich Grafts In The F/B/EVAR Era: Yes They Exist |
| Presenter(s):Martin Malina, MD, PhD | |
| View Slides in PDF | |
| 9:26 AM - 9:31 AM | Repair Of Juxta- And Pararenal AAAs Using A Combination Of Fenestrations And Chimney Grafts: Advantages, Techniques And Results |
| Presenter(s):Mark W. Mewissen, MD, RVT | |
| View Slides in PDF | |
| 9:32 AM - 9:37 AM | How To Rescue A F/EVAR Procedure When The Fenestrations Are Poorly Aligned With Branch Orifices: Why Does It Happen |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 9:38 AM - 9:43 AM | Main Graft Body Alignment With Branch Orifices Is Not An Issue With Parallel Grafts (Ch/EVAR) And How Do Variable Curvature Sheaths Help With Both F/EVAR And Ch/EVAR |
| Presenter(s):Jason T. Lee, MD | |
| View Slides in PDF | |
| 9:44 AM - 9:49 AM | DEBATE: Long-Term Results Of F/B/EVAR For Pararenal AAAs Show That It Should Be The Procedure Of Choice And TAAAs In Anatomically Suited Patients Which Is Most Of The Time |
| Presenter(s):Piergiorgio Cao, MD, FRCS | |
| View Slides in PDF | |
| 9:50 AM - 9:55 AM | DEBATE: Not So: Open Repair Still Has A Major Role For Treating Many Patients With Pararenal AAAs And TAAAs |
| Presenter(s):Thomas C. Bower, MD | |
| View Slides in PDF | |
| 9:56 AM - 10:01 AM | United Kingdom Assessment Of Countrywide Outcomes And Cost For Treating Complex AAAs: Is Endo Equal To Or Better Than Open Repair In Any Way |
| Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
| View Slides in PDF | |
| 10:02 AM - 10:10 AM | Panel Discussion |
| 10:10 AM - 10:20 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 41 | |
| SESSION 42 SCHEDULE | |
|
Wednesday
SESSION 42:
UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS; NEW DEVELOPMENTS IN TREATING ILIAC ANEURYSMS AND REVASCULARIZING HYPOGASTRIC ARTERIES
Moderators:Eric L.G. Verhoeven, MD, PhD / Rodney A. White, MD
|
|
| x | |
| UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS | |
| 10:20 AM - 10:25 AM | Multilayer Flow Modulating (MLFM) Uncovered Stents (From Cardiatis): Indications, Contraindications, Advantages And Results |
| Presenter(s):Rodney A. White, MD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | Why MLFM Uncovered Stents Should Be The First Choice For Treating Renal, Visceral And Popliteal Aneurysms And Possibly Other Lesions: Results Show That These Stents Preserve Branch Flow And Prevent Aneurysm Rupture |
| Presenter(s):Michel C. Henry, MD | |
| View Slides in PDF | |
| 10:32 AM - 10:37 AM | Role Of MLFM Uncovered Stents To Treat Type A Aortic Dissections: Indications, Advantages, Limitations And Results |
| Presenter(s):Victor S. Costache, MD, PhD | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | Value Of MLFM Uncovered Stents To Treat Aortic Dissections And Recurrent Emboli From Paroxysmal Atrial Fibrillation: They Prevent Emboli From Going To The Brain |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | Role Of MLFM Stents For Treating Type A And B Aortic Dissections: Indications And Results: What About For Complex Aneurysm Treatment |
| Presenter(s):Zoran Stankov, MD / Ivo Petrov, MD, PhD | |
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | MLFM Uncovered Stents For Treating Complex AAAs And TAAAs: What Do The Longer-Term Results From The Multicenter DRAGON Trial Show: Do These Stents Prevent Rupture |
| Presenter(s):Claude D. Vaislic, MD | |
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | Long-Term Follow-Up Of Multilayer Bare Stent Treatment Of TAAAs, Complex AAAs And Type B Aortic Dissections: The Moroccan Experience |
| Presenter(s):Amira Benjelloun, MD | |
| View Slides in PDF | |
| 11:02 AM - 11:07 AM | Panel Discussion |
| TREATMENT OF ILIAC ANEURYSM AND PRESERVING HYPOGASTRIC FLOW | |
| 11:07 AM - 11:12 AM | Comparing The Various Industry-Made Iliac Branch Devices (IBDs) For Treating Common And Internal Iliac Aneurysms: Advantages And Limitations Of Each: When To Use Which One |
| Presenter(s):Fabio Verzini, MD, PhD | |
| View Slides in PDF | |
| 11:13 AM - 11:18 AM | Advantages, Limitations And Results Of Unilateral And Bilateral Gore IBD To Treat AAAs With Iliac Aneurysms: Early Results From The International ICEBERG Registry |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 11:19 AM - 11:24 AM | How To Prevent Complications And Failure With The Gore IBD When The Anatomy Is Tortuous: What Is The Iliac Tortuosity Index And How Does It Help |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 11:25 AM - 11:30 AM | Value Of IBDs To Treat Isolated (No AAA) Common And Internal Iliac Aneurysms: At What Size Should They Be Treated: Which Device Is Best |
| Presenter(s):Giovanni Pratesi, MD | |
| View Slides in PDF | |
| 11:31 AM - 11:36 AM | Advantages And Limitations Of The Jotec-Cryolife IBD For Treating Common And Internal Iliac Aneurysms; This Device Works Well With The Endurant Endograft (Medtronic) |
| Presenter(s):Lee Bouwman, MD, PhD, MSc | |
| View Slides in PDF | |
| 11:37 AM - 11:42 AM | When The Anatomy Is Not Suitable For An IBD, How Can Hypogastric Flow Be Preserved: Sandwich Grafts, External Iliac-To-Hypogastric Grafts Open Or Endo With An Aorto-Uni-Iliac EVAR, Etc. |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 11:43 AM - 11:48 AM | How Common Iliac Aneurysms (CIAs) Have An Impact On Aortic Morphology: Why A New Classification System For CIAs Will Be Helpful |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 11:49 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor PromenadeVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 42 | |
| SESSION 43 SCHEDULE | |
|
Wednesday
SESSION 43:
INTERESTING NEW DEVELOPMENTS IN STANDARD EVAR AND INFRARENAL AAAs: ACCEPTABLE NECK ANATOMY; NEW GUIDELINES; AAA SAC THROMBUS AND SHRINKAGE; NEW CLASSIFICATION SYSTEM; EFFECT OF STEROIDS ON EVAR
Moderators:Elliot L. Chaikof, MD, PhD / Janet T. Powell, MD, PhD
|
|
| x | |
| 1:00 PM - 1:05 PM | AAA Sac Shrinkage Is A Good Marker Of Durable Success After EVAR: Which Endografts Have The Best Rates Of Sac Shrinkage |
| Presenter(s):Michael C. Stoner, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Large Diameter Of The Flow Lumen In AAAs Is A Risk Factor For A Poor Outcome After EVAR Just Like Large Proximal Neck Diameter: What Are The Reasons For These Observations |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Large Proximal Necks (> 28 mm In Diameter) Are Predictive Of A Poor Outcome From EVAR: Based On A Meta-Analysis |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Highlights From The New 2019 European (ESVS) AAA Guidelines: What Is Different And Better About Them |
| Presenter(s):Sebastian E. Debus, MD, PhD / Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Comparison Of The US (SVS) And ESVS AAA Guidelines: Why Are The US Guidelines Better |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Increasing Disparity Between The SVS Guideline AAA Indications For AAA Repair And Real World Practice: Are The Guidelines Relevant Currently |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | DEBATE: Increasing Volume Of Mural Clot Within An AAA Sac Does Not Increase The Rupture Risk |
| Presenter(s):Athanasios D. Giannoukas, MSc, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | DEBATE: Not So: Increasing Thrombus Volume Within An AAA Sac Correlates With Increasing Risk Of Complications And Rupture: What Is The Mechanism |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | A New Classification System For AAAs Helps In Understanding Their Behavior, In Determining Treatments And Evaluating Them |
| Presenter(s):Claude Mialhe, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Does Preprocedure Steroid Administration Before EVAR Produce A More Benign Postprocedure Course And Facilitate Earlier Discharge: What Is The Mechanism |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 2:00 PM - 2:06 PM | Panel Discussion |
| END OF SESSION 43 | |
| SESSION 44 SCHEDULE | |
|
Wednesday
SESSION 44:
MORE NEW DEVELOPMENTS IN AAA PATHOGENESIS, NATURAL HISTORY AND TREATMENT
Moderators:Ali F. AbuRahma, MD / Juan C. Parodi, MD
|
|
| x | |
| 2:06 PM - 2:11 PM | Inflammatory AAAs: Medical Treatment With Steroids Is Adequate For Many Patients With Them: What Is The Regimen And Results: When Is Invasive Treatment Needed – Open Or Endo |
| Presenter(s):Julien G. Sfeir, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | How Long Can Patients With Moderate Sized AAAs Safely Wait For Elective Repair: Rupture Risk For AAAs < 6.0 cm In Diameter Is Low And Overemphasized |
| Presenter(s):Richard G.J. Gibbs, FRCS | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Acceptable Results Can Be Achieved With EVAR Devices Used Outside IFU Requirements If Certain Precautions Are Followed: What Are They And What Are The Limitations |
| Presenter(s):Francesco Speziale, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Depleted Nutritional Status And Muscle Mass Increases The Risk Of Open AAA Repair: What About With EVAR |
| Presenter(s):Kimihiro Komori, MD, PhD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Why F/EVAR For Failed EVAR Is Not Simple: Technical Tips To Make It Work |
| Presenter(s):Barend M.E. Mees, MD, PhD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | A New Gene Family That May Be Vital In Causing AAAs: The Gene Can Be Identified From Skin Biopsies: How Can They Help In Diagnosis And Treatment |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Comparison Of Aortic Neck Dilatation After AAA Repair In Patients Undergoing EVAR Versus Open Repair: From The DREAM Trial Which Allows This Comparison To Be Made In Patients Suitable For Both Procedures |
| Presenter(s):Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | How Should AAA Shape (With An Eccentric Sac Or Two Sacs) Influence Indications For Repair: How Should Diameter Measurements Be Made In These Circumstances |
| Presenter(s):Jacques Busquet, MD | |
| View Slides in PDF | |
| 2:54 PM - 3:00 PM | Increasing Requirement For Open Conversion Following EVAR: Reasons For And Technical Tips: Why Is It More Often Required For A Persistent Type 2 Endoleak With An Enlarging AAA Sac |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:15 PM | Panel Discussion And BreakVisit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 44 | |
| SESSION 45 SCHEDULE | |
|
Wednesday
SESSION 45:
SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASES AND THEIR TREATMENT (4 ľ- MINUTE FAST PACED TALKS)
Moderators:Mark A. Adelman, MD / Michael L. Marin, MD
|
|
| x | |
| EVAR AND AAA RELATED TOPICS | |
| 3:15 PM - 3:20 PM | External Iliac To Internal Iliac Artery Bypass: Does It Have A Role In Preserving Hypogastric Flow In The Endo Era: Technical Tips |
| Presenter(s):Heron E. Rodriguez, MD | |
| View Slides in PDF | |
| 3:20 PM - 3:25 PM | Value And Indications For Preprocedural Embolization Of The IMA And Lumbar Arteries Before EVAR |
| Presenter(s):Timothy M. Sullivan, MD / Jesse Manunga, MD | |
| View Slides in PDF | |
| 3:25 PM - 3:30 PM | Increasing Role Of Endovascular Treatments And EVAR For Vascular Complications Of Connective Tissue Disorders |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 3:30 PM - 3:35 PM | Why Should Aortic AAA Neck Dilatation Differ After EVAR And After F/EVAR: Does It |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | EVAR Treatment Of Atypical AAAs: Technical Tips And Special Precautions |
| Presenter(s):Furuzan Numan, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | 5 Years After AAA Repair The Quality Of Life Is Better In Those Having EVAR Than In Those Having Open Repair |
| Presenter(s):Mauro Gargiulo, MD / Gianluca Faggioli, MD | |
| View Slides in PDF | |
| 3:45 PM - 3:50 PM | Why Do Fluoroquin Drugs Increase The Risk Of Aortic Aneurysms And Dissections |
| Presenter(s):Natzi Sakalihasan, MD, PhD | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | Panel Discussion |
| F/B/EVAR AND PARALLEL GRAFT RELATED TOPICS | |
| 3:55 PM - 4:00 PM | When With F/EVAR Should A Renal Or Mesenteric Branch Not Be Stented |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 4:00 PM - 4:05 PM | Avoid Complications And Problems From Parallel Grafts And How To Make Them Work Safely And Effectively |
| Presenter(s):Murray L. Shames, MD | |
| View Slides in PDF | |
| 4:05 PM - 4:10 PM | Update On In Situ Fenestration For Branch Revascularization: How To Use It For Renal And Mesenteric Branches In Urgent TAAA Repairs: Imaging Is Key And It Is Not Simple |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Multicenter Results Of The t-Branch Off-The-Shelf Graft (From Cook) For TAAA Repairs: Advantages, Technical Tips, Limitations |
| Presenter(s):Martin J. Austermann, MD | |
| View Slides in PDF | |
| AORTIC DISSECTION RELATED TOPICS | |
| 4:15 PM - 4:20 PM | The SKIRT Stent-Graft To Prevent Endoleaks From Fenestrated And Chimney TEVARs: How Does It Work |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | Troubleshooting Challenging TBADs During Endovascular Treatment And Making TEVAR Work Safely And Effectively |
| Presenter(s):Rami Tadros, MD / Michael L. Marin, MD | |
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | Branched Endografts For Treating Aortic Dissections: Which Graft For Which Patient And Anatomy: Technical Tips |
| Presenter(s):Luis A. Sanchez, MD | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Panel Discussion |
| END OF SESSION 45 | |
| SESSION 46 SCHEDULE | |
|
Wednesday
SESSION 46:
MORE SHORT HOT NEW TOPICS RELATED TO AORTIC AND CAROTID DISEASES AND THEIR TREATMENT (4 ľ-MINUTE FAST PACED TALKS)
Moderators:Luis A. Sanchez, MD / K. Wayne Johnston, CM, MD, FRCS
|
|
| x | |
| AORTA RELATED TOPICS | |
| 4:35 PM - 4:40 PM | International Comparison Of How AAAs Are Treated And How It Influences Results |
| Presenter(s):Pete Holt, MD, PhD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Long-Term Outcomes From The OVER RCT Comparing AAA Treatment With EVAR Versus Open Repair: How Are Results Similar And How Do They Differ From The EVAR 1 And DREAM RCTs And Why |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | At What Size Do Hypogastric Aneurysm Need To Be Treated: How Best To Do It And Technical Tips |
| Presenter(s):Darren B. Schneider, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | Safe F/B/EVAR In Patients With Chronic Kidney Disease: Intravascular Ultrasound (IVUS) Helps: Technical Tips |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | Acute Kidney Injury During F/B/EVAR: What Are The Long-Term Consequences And What Can Be Done To Prevent Or Treat It Better |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | Why Outcomes Of F/B/EVAR For Women Are Different Than Those For Men: What Are The Implications |
| Presenter(s):Tara M. Mastracci, MD | |
| View Slides in PDF | |
| 5:05 PM - 5:10 PM | Progress And Improvements In F/B/EVAR Decrease Complications And Improve Results |
| Presenter(s):Federico E. Parodi, MD | |
| View Slides in PDF | |
| 5:10 PM - 5:15 PM | New Developments In The Treatment And Results Of Aorto-Enteric Fistulas: From The Low Frequency Vascular Disease Consortium |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 5:15 PM - 5:20 PM | Technical Tips For AAA Sac Branch Embolization During EVAR: When And How To Do It And What Is Its Value |
| Presenter(s):Eric Allaire, MD, PhD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Panel Discussion |
| CAROTID RELATED TOPICS | |
| 5:25 PM - 5:30 PM | Mini-Incision CEA Is Safer, Cheaper And More Effective Than TCAR: How To Do It In Most Patients Needing Invasive Treatment |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | Update On Current Outcomes Of CEA And CAS In Women: What Are The Implications |
| Presenter(s):Caron B. Rockman, MD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | DEBATE: Screening For Carotid Disease Will Prevent Strokes And Should Be Expanded: To Whom |
| Presenter(s):George S. Lavenson, MD | |
| View Slides in PDF | |
| 5:40 PM - 5:45 PM | DEBATE: Not So: Screening More Widely For Carotid Disease Will Cause More Harm Than Benefit: Why |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 5:45 PM - 5:50 PM | Safety Of CEA And CAS In Patients With A History Of Coronary Artery Disease: From The 4 RCTs |
| Presenter(s):Gert J. de Borst, MD, PhD | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | Technical Tips And Indications For Eversion CEA: When Is It Best And When Not |
| Presenter(s):Timothy M. Sullivan, MD | |
| View Slides in PDF | |
| 5:55 PM - 6:00 PM | Panel Discussion End of Program F |
| END OF SESSION 46 | |
|
Thursday, November 21, 2019
Print Entire 2019 Program:
|
|
| SESSION 47 SCHEDULE | |
|
Thursday
SESSION 47:
EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES OR DEVICES
Moderators:Frans L. Moll, MD, PhD / Frank J. Veith, MD
|
|
| x | |
| 6:45 AM - 6:50 AM | Theoretically Promising Technologies Don’t Always Work Out: Reasons And Implications For Creative Vascular Surgeons And Specialists |
| Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | Lumee Implantable 02 Sensors; How Do They Work; How Accurate Are They And How Can They Help During And After Foot Revascularization Procedures: The OMNIA Trial |
| Presenter(s):Miguel F. Montero-Baker, MD | |
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | Iliac Artery Endofibrosis: External Iliac Occlusive Disease In Young Athletes (Especially Cyclists): Pathogenesis And Optimal Treatment – Endo Treatments Don’t Work |
| Presenter(s):Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | Progress In Transcatheter Aortic Valve Replacement (TAVR): An Interventional Cardiologist’s View |
| Presenter(s):Martin B. Leon, MD | |
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | Can Increased H20 Intake (> 2 liters/day) Improve Symptoms And Heal Lesions In Patients With Claudication And CLTI: What Is The Evidence: What Is The Mechanism: Will It Replace Some Invasive Therapy |
| Presenter(s):Juan C. Parodi, MD | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | Restricting Needed Transfusion In Patients Undergoing Vascular Procedures Is Bad Practice: So-Called Permissive Anemia After Vascular Operations Or Procedures Increases Morbidity And Mortality |
| Presenter(s):Panos Kougias, MD, MSc / Joseph L. Mills, MD | |
| View Slides in PDF | |
| 7:21 AM - 7:26 AM | Advantages Of Curved Balloons (Curved When Inflated) In Endovascular Procedures: How Do They Work And When Will They Be Available |
| Presenter(s):Timothy A.M. Chuter, DM | |
| View Slides in PDF | |
| 7:27 AM - 7:32 AM | A F/EVAR Device Automatically Computer Generated From CTA Images With Compensation For Device Induced Anatomic Changes And A Specialized Stent-Graft (BoulEVARd) For FEVAR Branches |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 7:33 AM - 7:38 AM | Non-Invasive Measurement Of Intra-Arterial Pressure Gradients And Vector Flow Imaging: Current Status And Value In Endovascular Treatments |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 7:39 AM - 7:44 AM | A New Retrievable Stent Device (The Rescue Stent) To Control Massive Aortic And Caval Bleeding Without Fluoroscopy: How Does It Work And Experience To Date |
| Presenter(s):Bryan W. Tillman, MD, PhD / Michel Makaroun, MD | |
| View Slides in PDF | |
| 7:45 AM - 7:50 AM | Update On The Art-Assist Device To Provide Pneumatic Sequential Compression For Ischemia: It Is The Best Treatment For Many CLTI Patients: How It Works And Results From A 20-Year Experience |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC | |
| View Slides in PDF | |
| 7:51 AM - 8:00 AM | Panel Discussion |
| END OF SESSION 47 | |
| SESSION 48 SCHEDULE | |
|
Thursday
SESSION 48:
NEW DEVELOPMENTS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs)
Moderators:Matthew J. Eagleton, MD / Mark A. Farber, MD
|
|
| x | |
| 8:00 AM - 8:05 AM | New Findings From The UK Complex AAA Multicenter Study Comparing Outcomes And Cost For F/B/EVAR Versus Open Repair For Juxta- And Pararenal AAAs And TAAAs |
| Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
| View Slides in PDF | |
| 8:06 AM - 8:11 AM | Update On The Results Of The French Multicenter Study Comparing Outcomes And Costs Of F/EVAR And Open Repair For Complex AAAs |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:12 AM - 8:17 AM | Update On Improving Results With F/B/EVAR For Complex AAAs: How Are The New Bridging Stent-Grafts And Inner Branched Grafts Helping And Making Procedures More Effective |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 8:18 AM - 8:23 AM | Expanded Use Of Preloaded Catheters And Wires For F/B/EVAR Treatment Of Complex AAAs And TAAAs: How Do They Work: Advantages And Limitations |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 8:24 AM - 8:29 AM | DEBATE: Longer Follow-Up And Good Outcomes Support The Continued And Wider Use Of Parallel Graft Repairs Of Complex AAAs |
| Presenter(s):Edward Y. Woo, MD | |
| View Slides in PDF | |
| 8:30 AM - 8:35 AM | DEBATE: Not So: Parallel Graft Use Should Be Decreasing: F/B/EVAR Is Best For Complex AAAs And TAAAs |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:36 AM - 8:41 AM | Long-Term Results Of Chimney EVAR (Ch/EVAR) From The PERICLES Registry Show Good Results Comparable To F/EVAR: How Can These Results Be Duplicated And Devices Gain Approval For This Usage |
| Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD | |
| View Slides in PDF | |
| 8:42 AM - 8:47 AM | Endovascular Docking Station To Make Parallel Graft TAAA Repair Safe And Dependable And Avoid Gutter Endoleaks With 4-Parallel Grafts (2 Chimney And 2 Sandwich Grafts) |
| Presenter(s):Manish Mehta, MD, MPH / James F. McKinsey, MD | |
| View Slides in PDF | |
| 8:48 AM - 8:53 AM | 3-Vessel Parallel Grafts Can Yield Good Results For Complex AAA Repair If Certain Techniques Are Used: From The PERICLES Registry: Technical Tips |
| Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD / Gergana Taneva, MD | |
| View Slides in PDF | |
| 8:54 AM - 8:59 AM | How To Prevent Gutter Endoleaks With Parallel Grafts By The “Eye Of The Tiger” Technique: When Is It Needed And How To Do It |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 9:00 AM - 9:05 AM | TAAA Repair With An Off-The-Shelf Multibranched Manifold Device: 7-Year Experience In < 100 Patients: Advantages, Limitations, Complications And Device Modifications To Avoid Them |
| Presenter(s):Patrick W. Kelly, MD | |
| View Slides in PDF | |
| 9:06 AM - 9:15 AM | Panel Discussion |
| 9:15 AM - 9:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 48 | |
| SESSION 49 SCHEDULE | |
|
Thursday
SESSION 49:
MORE ABOUT F/B/EVAR AND PARALLEL GRAFTS TO TREAT COMPLEX AAAs AND TAAAs
Moderators:James F. McKinsey, MD / Frank J. Veith, MD
|
|
| x | |
| 9:30 AM - 9:35 AM | DEBATE: Why 2-Vessel F/EVAR Is Different And Less Complex Than 3- Or 4-Vessel F/EVAR: The Latter Requires Different Techniques, Has More Complications And Worse Results |
| Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 9:36 AM - 9:41 AM | DEBATE: Not So: 4-Vessel F/EVARs Have Many Advantages In Many Patients And Are Not Substantially More Difficult |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 9:42 AM - 9:47 AM | Many Bridging Stent-Grafts Are Now Available For F/B/EVAR Renal And Visceral Branches: Advantages And Limitations Of Each: Which Is Best In What Circumstance |
| Presenter(s):Giovanni F. Torsello, MD / Giovanni Torsello, MD | |
| View Slides in PDF | |
| 9:48 AM - 9:53 AM | For F/B/EVAR Treatment Of Complex AAAs And TAAAs What Are The Indications For And The Value And Disadvantages Of Fenestrations, Outer Branches And Inner Branches: Comparison Of Cook And Jotec Devices |
| Presenter(s):Ciro Ferrer, MD / Piergiorgio Cao, MD, FRCS | |
| View Slides in PDF | |
| 9:54 AM - 9:59 AM | F/B/EVAR To Treat Failed EVARs: What Are The Challenges: Technical Tips To Make A Difficult Procedure Easier |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 10:00 AM - 10:05 AM | DEBATE: The Evidence To Support The Success And Durability Of Ch/EVAR For Complex AAAs Is Solid: If Done Right, Ch/EVAR Is Equal To F/EVAR And Has Real Advantages |
| Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD | |
| View Slides in PDF | |
| 10:06 AM - 10:11 AM | DEBATE: Not So: F/EVAR Is The Gold Standard For Complex AAAs And Has Better Outcomes: Ch/EVAR Is A Dying Procedure |
| Presenter(s):Tara M. Mastracci, MD | |
| View Slides in PDF | |
| 10:12 AM - 10:17 AM | What Anatomy Is Unsuitable For F/EVAR With The Cook Z-FEN Device: When Can This Device Be Used Successfully Outside Its IFU |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 10:18 AM - 10:23 AM | Technique For Safe Percutaneous Axillary Access For F/B/EVAR And Ch/EVAR Using Ultrasound, Closure Devices, Through And Through Wire And Balloon Control |
| Presenter(s):Germano Melissano, MD / Luca Bertoglio, MD / Roberto Chiesa, MD | |
| View Slides in PDF | |
| 10:24 AM - 10:29 AM | Update On The Value Of Variable Curvature Sheaths For F/B/EVAR: They Make Upper Extremity Access Largely Unnecessary And Decrease Radiation Exposure, Contrast Dose And Procedure Time |
| Presenter(s):Joshua D. Adams, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:35 AM | Importance Of Secondary Procedures After F/B/EVAR: Indications, Type Of Interventions And Impact On Outcomes |
| Presenter(s):Salvatore T. Scali, MD | |
| View Slides in PDF | |
| 10:36 AM - 10:45 AM | Panel Discussion |
| END OF SESSION 49 | |
| SESSION 50 SCHEDULE | |
|
Thursday
SESSION 50:
A TRIBUTE TO OUR MILITARY AND SERVICE PHYSICIANS: MILITARY HISTORY, CONTROL AND TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES, CURRENT COMBAT CONDITIONS AND VALUE OF A TISSUE ENGINEERED VASCULAR GRAFT(6-MINUTE TALKS)
Moderators:Eric A. Elster, MD / Todd E. Rasmussen, MD, FACS
|
|
| x | |
| 10:45 AM - 10:51 AM | A Tribute To J. Leonel Villavicencio, MD (1927-2019): A Vascular Surgery Star And An Outstanding Military Surgeon |
| Presenter(s):Eric A. Elster, MD | |
| View Slides in PDF | |
| 10:52 AM - 11:04 AM | A Heroic Rescue And Battle From The War In Afghanistan: 20 US Airborne Army Rangers And 7 Navy SEALS Take On 400 Taliban Attackers And Win At Takurghar |
| Presenter(s):Wayne F. Yakes, MD | |
| View Slides in PDF | |
| 11:05 AM - 11:11 AM | What A Military Vascular Surgeon Is Currently Doing In Afghanistan And Why US Forces Must Stay There |
| Presenter(s):Zachary M. Arthurs, MD | |
| View Slides in PDF | |
| 11:12 AM - 11:18 AM | Comparison Of Current Treatments Of Combat And Civilian Vascular Injuries In Israel: When Open; When Endovascular |
| Presenter(s):Samy S. Nitecki, MD | |
| View Slides in PDF | |
| 11:19 AM - 11:25 AM | Role Of Military Medicine In Improving National Preparedness: Advances In Homeland Security And Department Of Defense Combat Casualty Care |
| Presenter(s):Todd E. Rasmussen, MD, FACS / Eric A. Elster, MD | |
| View Slides in PDF | |
| 11:26 AM - 11:32 AM | Advantages And Limitations Of Tourniquet Use In Military And Civilian Limb Vascular Trauma: Tourniquets Saves Lives If Used Properly |
| Presenter(s):Michael Engelhardt, MD | |
| View Slides in PDF | |
| 11:33 AM - 11:39 AM | The Humacyte Bioengineered Arterial Substitute For Traumatic Injuries And Other Vascular Lesions: Current Status Update And Value Of A Civilian-Military Partnership |
| Presenter(s):Jeffrey H. Lawson, MD, PhD | |
| View Slides in PDF | |
| 11:40 AM - 11:46 AM | Updated Military Experience With REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) And Endovascular Resuscitation |
| Presenter(s):Joseph J. DuBose, MD | |
| View Slides in PDF | |
| 11:47 AM - 11:53 AM | Update On Civilian Use Of REBOA In Trauma And Other Conditions Including Cardiac Arrest: Advantages And Disadvantages |
| Presenter(s):Tal M. Hörer, MD, PhD | |
| View Slides in PDF | |
| 11:54 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 50 | |
| SESSION 51 SCHEDULE | |
|
Thursday
SESSION 51:
NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED ABDOMINAL AORTIC ANEURYSMS (RAAAs)
|
|
| x | |
| 1:00 PM - 1:05 PM | Value Of Telemedicine In The Management Of Patients With RAAAs |
| Presenter(s):Nobuyoshi Azuma, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Risk Evaluation Scores And Systems Are Inaccurate And Do Not Help In The Management Of RAAA Patients: They Cannot Predict Patients Who Should Be Denied Treatment |
| Presenter(s):Janet T. Powell, MD, PhD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | With Adjuncts Such As Chimney Grafts And Onyx, 100% Of RAAA Patients Can And Should Be Treated By EVAR |
| Presenter(s):Thomas Larzon, MD, PhD / Mario L. Lachat, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | The Debate Is Over: EVAR Is The Best Treatment For RAAA Patients – Even If The RCTs Show Otherwise |
| Presenter(s):Martin Malina, MD, PhD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | The IMPROVE RCT Comparing EVAR To Open Repair For RAAAs Finally Showed Late Survival Is Better For EVAR: What Did The AJAX RCT Show Regarding Late Survival After RAAA Repair |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | EVAR Outcomes Are Improving In RAAA Patients: EVAR Should Be The Standard Of Care In Most RAAA Patients: Which RAAA Patients Currently Should Get Open Repair |
| Presenter(s):Anders Wanhainen, MD, PhD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Techniques For Rapid Percutaneous Access And Quick Contralateral Gate Cannulation In RAAA Patients: Technical Tips |
| Presenter(s):Felice Pecoraro, MD / Mario L. Lachat, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | How Should Aortic Endografts Be Sized In Hypotensive RAAA Patients: CTA Measurements May Be Misleading |
| Presenter(s):Zoran Rancic, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Why Have Survival Rates For RAAA Patients Improved In Recent Years: It Is Not Just The Increasing Use Of EVAR |
| Presenter(s):Martin Bjorck, MD, PhD / | |
| View Slides in PDF | |
| 1:54 PM - 2:00 PM | Why The Endologix Ovation Alto Device Has Advantages For EVAR Treatment Of RAAAs: It Eliminates The Need For Supraceliac Aortic Balloon Control: How So |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:08 PM | Panel Discussion |
| END OF SESSION 51 | |
| SESSION 52 SCHEDULE | |
|
Thursday
SESSION 52:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF RAAAs AND RUPTURED JUXTA- AND PARARENAL AAAs AND TAAAs
Moderators:Manish Mehta, MD, MPH / Martin Bjorck, MD, PhD
|
|
| x | |
| 2:08 PM - 2:13 PM | After EVAR For RAAAs Sac Shrinkage Is Greater Than After Elective EVAR: But Survival Is Similar: What Are The Explanations |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 2:14 PM - 2:19 PM | Update On Improvements In The Diagnosis And Treatment Of Abdominal Compartment Syndrome (ACS) After EVAR For RAAAs |
| Presenter(s):Martin Bjorck, MD, PhD / Mario L. Lachat, MD | |
| View Slides in PDF | |
| 2:20 PM - 2:25 PM | DEBATE: Surgeon Modified Endografts Or Off-The-Shelf Devices Are The Best Way To Treat Ruptured Complex AAAs (Juxta- Or Pararenal) |
| Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
| View Slides in PDF | |
| 2:26 PM - 2:31 PM | DEBATE: Not So: Ch/EVAR Is The Best Way To Treat Ruptured Complex AAAs |
| Presenter(s):Mario L. Lachat, MD / Konstantinos P. Donas, MD / Drosos Kotelis, MD | |
| View Slides in PDF | |
| 2:32 PM - 2:37 PM | Periodontal Inflammatory Disease With Gram Negative Pockets May Cause Rapid AAA Growth And Instability: How Should It Be Treated In Patients With Small AAAs |
| Presenter(s):Natzi Sakalihasan, MD, PhD | |
| View Slides in PDF | |
| 2:38 PM - 2:43 PM | Finnish Nationwide Study Shows That Most RAAA Patients Never Reach A Hospital And Many RAAA Patients Are Not Picked Up By AAA Screening: Are These Findings True In Other Countries And How Can They Be Fixed |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 2:44 PM - 2:49 PM | In Japan: EVAR Is The Best Treatment For RAAAs: The Surprising Significance Of Retroperitoneal Hematoma Volume |
| Presenter(s):Naoki Fujimura, MD, PhD | |
| View Slides in PDF | |
| 2:50 PM - 2:55 PM | Total Endovascular Repair Of Ruptured TAAAs: What Graft Is Best: Why These Ruptures Are Usually Contained And Slowly Evolving: Technical Tips |
| Presenter(s):Gianluca Faggioli, MD / Mauro Gargiulo, MD / Andrea Stella, MD | |
| View Slides in PDF | |
| 2:56 PM - 3:01 PM | Endovascular Repair Of Ruptured TAAAs: European Multicenter Results: What Endografts Were Used: Management And Technical Tips |
| Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 3:02 PM - 3:10 PM | Panel Discussion |
| 3:10 PM - 3:20 PM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 52 | |
| SESSION 53 SCHEDULE | |
|
Thursday
SESSION 53:
EXCITING NEW OR IMPROVED TECHNIQUES, CONCEPTS AND DEVICES; UPDATES ON EVOLVING ENDOVASCULAR TREATMENTS
Moderators:Reese A. Wain, MD / Patrick J. Lamparello, MD
|
|
| x | |
| 3:20 PM - 3:25 PM | Improved Less Invasive Technique For Anterior Lumbar Spine Exposure For Interbody Fusion: Complications And How To Avoid Them |
| Presenter(s):Christian Ochoa, MD | |
| View Slides in PDF | |
| 3:26 PM - 3:31 PM | Endovascular Treatment Of Vascular Complications Of Kidney Transplantation: These Complications Are More Frequent Than One Might Think |
| Presenter(s):Maria A. Ruffino, MD, EBIR | |
| View Slides in PDF | |
| 3:32 PM - 3:37 PM | How Computational Fluid Dynamic Analyses Can Help In Determining The Optimal Treatment Of Aortic Lesions |
| Presenter(s):James C. Stanley, MD / C. Alberto Figueroa, PhD / Christopher Tossas, BS / Theodorus van Bakel, MD, PhD | |
| View Slides in PDF | |
| 3:38 PM - 3:43 PM | Use Of Thoracic Stent-Grafts To Control Major Iliac Vein Or Caval Bleeding From Trauma Or During Open Surgery: How To Do It |
| Presenter(s):Geert Willem H. Schurink, MD, PhD | |
| View Slides in PDF | |
| 3:44 PM - 3:49 PM | Technical Tips For Safe Antegrade Common Femoral Artery (CFA) Access: It Should Have Similar Complication Rates To Standard Retrograde CEA Access: From The VQI |
| Presenter(s):Jeffrey J. Siracuse, MD, RPVI, FACS | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | The Aortyx Patch: What Is It And How Does It Work To Repair Focal Aortic Defects With Loss Of Tissue |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 3:56 PM - 4:01 PM | A Sirolimus External Patch To Prevent Anastomotic Intimal Hyperplasia When Placed Around The Distal Anastomosis Of A PTFE Fempop Arterial Graft |
| Presenter(s):Sriram S. Iyer, MD, FACC | |
| 4:02 PM - 4:07 PM | Panel Discussion |
| 4:07 PM - 4:12 PM | Left Gastric Embolization To Treat Obesity: Indications, Technique And How Effective Is It |
| Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
| View Slides in PDF | |
| 4:13 PM - 4:18 PM | Current Status Of Prostate Artery Embolization For Benign Prostatic Hypertrophy: Will It Replace Surgery; Technical Requirements And Results From A Meta-Analysis |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 4:19 PM - 4:24 PM | Occlusion Perfusion Catheter (From Advanced Catheter Therapies) To Inject Paclitaxel Or Other Drugs Into The Arterial Wall After Atherectomy: How Does It Work And 1-Year Results |
| Presenter(s):Lawrence A. Garcia, MD / George L. Adams, MD | |
| View Slides in PDF | |
| 4:25 PM - 4:30 PM | Preservation Of A Favorable Aortic Bifurcation During AAA Repair (Open And Endo) To Facilitate Later Contralateral Approaches For Lower Extremity Occlusive Disease: How To Do It |
| Presenter(s):Sigrid Nikol, MD | |
| View Slides in PDF | |
| 4:31 PM - 4:36 PM | Mini-Incision Open AAA Repair: When And How To Do It |
| Presenter(s):Kamphol Laohapensang, MD | |
| View Slides in PDF | |
| 4:37 PM - 4:42 PM | External Support Of Vein Grafts For Lower Extremity Bypasses: When Is It Helpful And How To Do It |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 4:43 PM - 4:48 PM | Panel Discussion |
| END OF SESSION 53 | |
| SESSION 54 SCHEDULE | |
|
Thursday
SESSION 54:
MORE ABOUT NEW CONCEPTS, DEVICES AND TECHNIQUES; PROGRESS IN RADIATION SAFETY
|
|
| x | |
| 4:48 AM - 4:53 AM | V-Healthy And V-Awareness Programs To Enhance Public Awareness Of Vascular Diseases And What Can Be Currently Done To Treat It Effectively |
| Presenter(s):Manish Mehta, MD, MPH | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Status Of Credentialing For Vascular Outpatient Centers And OBLs: What Organization Or Society Is Leading The Initiative |
| Presenter(s):Anton N. Sidawy, MD, MPH | |
| View Slides in PDF | |
| 5:00 PM - 5:05 PM | How To Do Perfusion Angiography To Assess Foot Circulation And Adequacy Of Treatment: Value In Diabetic Gangrene And Ulceration |
| Presenter(s):Jim Reekers, MD, PhD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | How To Create A Poor Man’s Variable Curve/Deflection Sheath That Is Stable: How To Make It And Value In F/B/EVAR: It Can Minimize The Need For Axillary Access |
| Presenter(s):Tilo Koelbel, MD, PhD | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | A New EVAR Endograft With Thrombogenic Fibers: It Decreases Endoleaks And Promotes Sac Shrinkage: How Does It Work And Favorable 2-Year Results (Kardiozis From Affluent Medical) |
| Presenter(s):Dominique Fabre, MD | |
| View Slides in PDF | |
| ADVANCES IN RADIATION SAFETY | |
| 5:18 PM - 5:23 PM | New Developments In Radiation Safety To Decrease Exposure To The Staff And Patients: What Is Claimed To Work But Does Not And What Works |
| Presenter(s):Lindsay Machan, MD | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | How Can Simulation Help To Promote Radiation Safety For Operators And Staff Members |
| Presenter(s):Lars B. Lonn, MD, PhD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | New Methods To Quantitate And Minimize Radiation Exposure To Personnel During Endovascular Procedures: Why Consequences From Given Exposure Vary Between Individuals: Can This Variability Be Determined |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | What Is New In Radiation Protection For Pregnant Physicians, Other Staff Members And Patients |
| Presenter(s):Palma M. Shaw, MD | |
| View Slides in PDF | |
| 5:42 PM - 5:47 PM | Technical Tips And New Technologies To Decrease Radiation Exposure During Complex Aortic Procedures: IVUS, Fusion, Virtual Reality, New Non-Xray Endovascular Guidance Systems |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 5:48 PM - 5:53 PM | Radiation Treatment For Lung Or Esophageal Cancer Can Cause Aortic Ruptures: Endografts Can Prevent Or Treat The Problem |
| Presenter(s):Maciej L. Dryjski, MD, PhD | |
| View Slides in PDF | |
| 5:54 PM - 6:02 PM | Panel Discussion End of Program G |
| END OF SESSION 54 | |
| SESSION 55 SCHEDULE | |
|
Thursday
SESSION 55:
NEW OR IMPROVED DEVICES FOR STANDARD INFRARENAL EVAR PROCEDURES AND STRATEGIES FOR OPEN AAA REPAIR TRAINING
Moderators:Wesley S. Moore, MD / Mark A. Adelman, MD
|
|
| x | |
| 6:45 AM - 6:50 AM | Current Status Of The Treo Endograft (Terumo Aortic) For EVAR In Europe And The US: Advantages And Limitations |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | The Altura Endograft For EVAR Repairs Of Standard Infrarenal AAAs: It Has A Double D Configuration In The Proximal Neck: Advantages, Limitations And 5-Year Results |
| Presenter(s):Dainis K. Krievins, MD / Albrecht H. Kramer, MD | |
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | Updated 2-Year Results Of The LEOPARD RCT Comparing The AFX (Endologix) Endograft To Other Standard Endografts For AAA Repair |
| Presenter(s):Christopher J. Kwolek, MD, MBA | |
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | Will Newer Lower Profile EVAR Devices Make A Positive Or Negative Difference On Outcomes And Availability Of EVAR |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | There Are Fewer Type 2 Endoleaks With The Gore Excluder Endograft Than Other EVAR Devices: What Is The Reason |
| Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | Update On The Ovation Polymer Based Endograft (Endologix) Without And With Chimney Grafts: Advantages, Limitations And 5-Year Results |
| Presenter(s):Venkatesh G. Ramaiah, MD | |
| View Slides in PDF | |
| 7:21 AM - 7:26 AM | Why The ALTO (Ovation) Endograft Has Advantages For AAA Repair: How Does Raising Its Polymer Proximal Sealing Ring Improve EVAR Applicability Based On Early Results |
| Presenter(s):Sean P. Lyden, MD | |
| View Slides in PDF | |
| 7:27 AM - 7:33 AM | Panel Discussion |
| 7:33 AM - 7:38 AM | Long-Term (10-Year) Follow-Up After EVAR With The Cook Zenith Endograft Shows It To Be Durable And Effective: Are There Any Downsides |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 7:39 AM - 7:44 AM | Update On The Cook Alpha Device For EVAR: Advantages, Limitations And Results |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
| View Slides in PDF | |
| 7:45 AM - 7:50 AM | The Gore Conformable Excluder With Active Proximal (Neck) Angulation Control: Results Of US IDE Trial To Date: Advantages And Limitations |
| Presenter(s):Robert Y. Rhee, MD | |
| View Slides in PDF | |
| 7:51 AM - 7:56 AM | European Results With The Gore Conformable AAA Endograft With Active Proximal Angulation Control |
| Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
| View Slides in PDF | |
| 7:57 AM - 8:02 AM | The Low Profile Incraft (From Cordis-Cardinal Health) For EVAR Has Real Advantages Based On Midterm Results From The Italian Multicenter Experience: The Device Is Now FDA Approved |
| Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD / Franco Grego, MD | |
| View Slides in PDF | |
| 8:03 AM - 8:08 AM | How Use Of Regional Referral Centers Can Remedy The Shortfall Of Vascular Surgical Training In Open AAA Repair In The EVAR, F/EVAR Era |
| Presenter(s):Lee Kirksey, MD | |
| View Slides in PDF | |
| 8:09 AM - 8:15 AM | Panel Discussion |
| END OF SESSION 55 | |
| SESSION 56 SCHEDULE | |
|
Thursday
SESSION 56:
MORE NEW OR UPDATED INFORMATION ABOUT NON-STANDARD DEVICES FOR EVAR OR ENDOVASCULAR ANEURYSM SEALING (EVAS) (TALKS ARE 4 3/4 OR 5 MINUTES)
|
|
| x | |
| 8:15 AM - 8:20 AM | Why AAA Sac Filling Endografts Like Nellix May Be Better Devices For Endo AAA Repair: What Are Their Disadvantages |
| Presenter(s):Venkatesh G. Ramaiah, MD | |
| View Slides in PDF | |
| 8:21 AM - 8:26 AM | Prevention Of Endoleaks After EVAR With A New Sac Filling Polymer Based Device: How It Works And What Is Its Status |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 8:27 AM - 8:32 AM | Advantages Of The Ovation Endograft (Endologix) For AAA Repair: Why The Polymer Filled Sealing Rings Are A Better Way To Secure And Maintain A Proximal Seal: Value Of The New Alto Modification |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 8:33 AM - 8:38 AM | Status Report On The Endologix Nellix Endograft For EVAS: Advantages, Limitations, Precautions And When Should It Be Used |
| Presenter(s):Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 8:39 AM - 8:44 AM | Evolution Of Nellix And EVAS: From A Single Center 295-Patient Experience: Advantages And Limitations |
| Presenter(s):Pete Holt, MD, PhD / | |
| View Slides in PDF | |
| 8:45 AM - 8:50 AM | Panel Discussion |
| 8:50 AM - 8:55 AM | Pros And Cons Of Nellix EVAS: From An Early Enthusiast: What Is Its Future And How Does It Decrease Post-Procedure Mortality |
| Presenter(s):Andrew Holden, MBChB | |
| View Slides in PDF | |
| 8:56 AM - 9:01 AM | Current Role And Value Of Nellix EVAS In A Busy EVAR Practice: How Best To Detect And Manage Failures |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 9:02 AM - 9:07 AM | Nellix In Nellix Procedure For Failed EVAS: Technical Challenges And Tips To Overcome Them |
| Presenter(s):Piotr Szopinski, MD, PhD | |
| View Slides in PDF | |
| 9:08 AM - 9:13 AM | What Are The Definitive Advantages Of EVAS That Prompt Its Continued Use |
| Presenter(s):Daniel G. Clair, MD | |
| View Slides in PDF | |
| 9:14 AM - 9:19 AM | Chimney EVAS: When Should It Be Used: Advantages And Technical Tips To Do It Safely And Effectively |
| Presenter(s):William J. Quinones-Baldrich, MD | |
| View Slides in PDF | |
| 9:20 AM - 9:26 AM | Panel Discussion |
| 9:26 AM - 9:40 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 56 | |
| SESSION 57 SCHEDULE | |
|
Thursday
SESSION 57:
NEW OR UPDATED ENDOVASCULAR DEVICES FOR TREATING ANEURYSMS AND OTHER LESIONS IN OR NEAR THE AORTIC ARCH (5-MINUTE TALKS)
|
|
| x | |
| 9:40 AM - 9:45 AM | Update On The Nexus Off-The-Shelf Single Branch Device For Treating Lesions Involving The Entire Aortic Arch (Zone 0 Lesions): Unique Advantages, Precautions And Midterm Results |
| Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | Terumo Aortic 2 Inner Branched Relay Device For Treating Aortic Arch Lesions: Advantages, Limitations And Early Registry Results |
| Presenter(s):Piergiorgio Cao, MD, FRCS / Ciro Ferrer, MD | |
| View Slides in PDF | |
| 9:52 AM - 9:57 AM | Gore Single Branched Device For Revascularizing The Left Subclavian Artery For Aortic Lesions Near The Arch Or More Complex Arch Lesions: Current Status, Advantages, Precautions And Results |
| Presenter(s):Michael D. Dake, MD / Michel Makaroun, MD | |
| View Slides in PDF | |
| 9:58 AM - 10:03 AM | Medtronic Valiant Mona LSA Single Branch Endograft For TEVAR Treatment Of Aortic Lesion Involving Or Near To The Left Subclavian Artery: Advantages, Precautions And Midterm Results |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 10:04 AM - 10:09 AM | More About The Valiant Mona LSA Single Branched TEVAR Device: Why Use It In Preference To A Chimney Or Periscope Parallel Graft |
| Presenter(s):Herve Rousseau, MD, PhD | |
| View Slides in PDF | |
| 10:10 AM - 10:15 AM | Custom-Made Scallops In Relay TEVAR: Results Of The French “REP” Study: A Step Forward To An Off-The-Shelf Device |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 10:16 AM - 10:22 AM | Panel Discussion |
| END OF SESSION 57 | |
| SESSION 58 SCHEDULE | |
|
Thursday
SESSION 58:
NEW OR UPDATED ENDOVASCULAR DEVICES FOR TREATING DESCENDING AORTIC LESIONS (TEVAR) AND TAAAs (5-MINUTE TALKS)
Moderators:Ramon Berguer, MD, PhD / Thomas S. Maldonado, MD
|
|
| x | |
| 10:22 AM - 10:27 AM | Is TEVAR Device Integrity Compromised By Low Profile Devices |
| Presenter(s):James H. Black III, MD | |
| View Slides in PDF | |
| 10:28 AM - 10:33 AM | Long-Term Outcomes Of TEVAR With Low Profile Devices: Which Ones Are Durable; Which Are Not |
| Presenter(s):Giovanni F. Torsello, MD / Giovanni Torsello, MD / Martin J. Austermann, MD | |
| View Slides in PDF | |
| 10:34 AM - 10:39 AM | How Does The New Valiant Navion Low Profile Endograft Expand The Therapeutic Options For TEVAR: Early Experience |
| Presenter(s):Ali Azizzadeh, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:45 AM | Valiant Navion Low Profile And Captiva Devices (From Medtronic) For TEVAR: Advantages For Various Aortic Lesions |
| Presenter(s):Fabio Verzini, MD, PhD | |
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | Value Of The New Low Profile Relay Pro Endograft (From Terumo Aortic) For TEVAR In Patients With Thoracic Aortic Aneurysms And Dissections: Advantages Over The Relay Plus Device |
| Presenter(s):Edward Y. Woo, MD / Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Advantages Of The Relay Plus Endograft For TEVAR: Why Does It Have A Lower Stroke Rate Than Other TEVAR Devices |
| Presenter(s):Mahmoud B. Malas, MD, MHS / Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | Value Of The Relay Pro Low Profile Device For TEVAR In Blunt Thoracic Aortic Injuries: Why It Is Advantageous |
| Presenter(s):Benjamin W. Starnes, MD | |
| View Slides in PDF | |
| 11:04 AM - 11:09 AM | Advantages Of A New Gore Conformable C-Tag Endograft For TEVAR: It Has Active Proximal Angulation Control To Deal With Complex Aortic Arch Angles; And Staged Deployment To Avoid Aortic Flow Interruption And Get Accurate Positioning Without The Need For Rapid Pacing |
| Presenter(s):Dittmar Boeckler, MD / Giovanni Torsello, MD | |
| View Slides in PDF | |
| 11:10 AM - 11:17 AM | Panel Discussion |
| 11:17 AM - 11:22 AM | Update On Worldwide Results With The Anaconda Fenestrated Endograft For Repair Of Juxta- And Pararenal AAAs: Advantages And Limitations: From The FACT Registry |
| Presenter(s):Clark J. Zeebregts, MD, PhD | |
| View Slides in PDF | |
| NEW ENDOVASCULAR DEVICES TO TREAT TAAAs | |
| 11:23 AM - 11:28 AM | New Hybrid Device (Open And Endo) To Treat TAAAs: Thoracoflo From Terumo Aortic: How It Works, Advantages And Early Clinical Results |
| Presenter(s):Sebastian E. Debus, MD, PhD | |
| View Slides in PDF | |
| 11:29 AM - 11:34 AM | The Gore TAMBE Endovascular Device To Treat TAAAs: Device Evolution, Current Status, Advantages And Results |
| Presenter(s):Mark A. Farber, MD / Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | The Valiant Off-The-Shelf Manifold Device (From Medtronic) For Treating TAAAs: How Does It Work, Advantages, Early Clinical Experience And Present Status |
| Presenter(s):Murray L. Shames, MD / Patrick W. Kelly, MD | |
| View Slides in PDF | |
| 11:41 AM - 11:46 AM | Update On The Colt Multibranched Manifold Device For Treating TAAAs: Clinical Experience And Present Status |
| Presenter(s):Piotr Szopinski, MD, PhD | |
| View Slides in PDF | |
| 11:47 AM - 11:52 AM | Physician Modifications To The Excluder Endograft To Make It Effective For Treating TAAAs: Technique And Results |
| Presenter(s):Wayne W. Zhang, MD | |
| View Slides in PDF | |
| 11:53 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 58 | |
| SESSION 59 SCHEDULE | |
|
Thursday
SESSION 59:
NEW OR UPDATED INFORMATION ON LOWER EXTREMITY PROSTHETIC GRAFTS OR STENT-GRAFTS FOR TREATMENT OF OCCLUSIVE DISEASE AND OTHER USES; VALUE OF HYBRID GRAFTS (PARTIALLY STENTED) FOR RENAL-VISCERAL DEBRANCHING (SEE ALSO SESSION 28)
Moderators:Enrico Ascher, MD / Keith D. Calligaro, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Cryopreserved Vein Allografts For Lower Extremity Bypasses: Indications, Value, Advantages And Limitations |
| Presenter(s):Robyn A. Macsata, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Increasing Usage And Value Of Covered Stents Are Facilitated By Newly Available Devices: What Are The New Devices And What Benefits Do They Provide |
| Presenter(s):Paulo E. Ocke Reis, MD, PhD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Broadening Applications And Value Of Balloon Expandable Covered Stents: The VBX Covered Stent From Gore |
| Presenter(s):W. Anthony Lee, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Value Of The VBX Balloon Expandable Stent-Graft In Treating Challenging Aorto-Iliac Occlusive Lesions: 3-Year Results, Advantages And Limitations |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Advantages Of Balloon Expandable Covered Bridging Stents In F/B/EVAR Procedures: Which One Is Best And Why |
| Presenter(s):Mauro Gargiulo, MD / Gianluca Faggioli, MD / Andrea Stella, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Positive 3-Year Results With The iCAST Balloon Expandable Covered Stents For Iliac Occlusive Disease: From The iCARUS Trial Comparing Them To VBX FLEX And Bolster Covered Stents |
| Presenter(s):John R. Laird, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Value Of Gore Hybrid Partially Stented PTFE Stent-Graft For Renal And Visceral Debranching Procedures To Treat Complex AAAs: How To Use Them |
| Presenter(s):Francesco Setacci, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:48 PM | Panel Discussion |
| END OF SESSION 59 | |
| SESSION 60 SCHEDULE | |
|
Thursday
SESSION 60:
NEW OR UPDATED DEVICES FOR LOWER EXTREMITY TREATMENTS: STENTS, BALLOONS, TACKS AND ATHERECTOMY DEVICES
Moderators:Dierk Scheinert, MD / Fred A. Weaver, MD, MMM
|
|
| x | |
| 1:48 PM - 1:53 PM | 2-Year Follow-Up Findings And Results From The Lutonix BTK DCB Global Registry |
| Presenter(s):Michael K.W. Lichtenberg, MD / Dierk Scheinert, MD | |
| View Slides in PDF | |
| 1:53 PM - 1:58 PM | Novel Angioplasty Balloon With Integrated Distal Embolic Protection Filter (Vanguard System From Contego Medical) For Use With Lesions Having High Embolic Potential: How It Works And Results Of The ENTRAP Study |
| Presenter(s):Thomas Zeller, MD | |
| View Slides in PDF | |
| 1:58 PM - 2:03 PM | Update On Results And Value Of The Chocolate Touch DCB (QT Vascular - Medtronic) To Minimize Dissection During Balloon Angioplasty |
| Presenter(s):Jos C. van den Berg, MD, PhD / Mehdi H. Shishehbor, DO, MPH, PhD | |
| View Slides in PDF | |
| 2:03 PM - 2:08 PM | The Biomimics 3D Helical Swirling Flow Inducing Stent (From Veryan Medical): 2-Year Results Of The MIMICS-2 Trial Show It Works Well For Complex Fempop Lesions: Now FDA Approved |
| Presenter(s):Thomas Zeller, MD / Peter Gaines, MD / Timothy M. Sullivan, MD / Michael K.W. Lichtenberg, MD | |
| View Slides in PDF | |
| 2:08 PM - 2:13 PM | What Is The Ideal Stent To Use When Fempop Angioplasty With A DCB Fails Early; Late |
| Presenter(s):Stefan Mueller-Huelsbeck, MD | |
| View Slides in PDF | |
| 2:13 PM - 2:18 PM | The Tigris Dual Component Stent (PTFE/Nitinol – From Gore): Is It Better And Why: Results From Multicenter Registries |
| Presenter(s):Maria A. Ruffino, MD, EBIR / Martin Werner, MD | |
| View Slides in PDF | |
| 2:19 PM - 2:29 PM | Panel Discussion |
| 2:29 PM - 2:34 PM | Tack Optimized Balloon Angioplasty With The Tack Endovascular System (From Intact Vascular) To Eliminate Dissections After Angioplasty: How Does This Device Work; Why It Is Better Than Stents; The TOBA Trials Show It Works Above The Knee: Now FDA Approved |
| Presenter(s):Marianne Brodmann, MD / Peter A. Schneider, MD | |
| View Slides in PDF | |
| 2:34 PM - 2:39 PM | How Well Does The Tack Endovascular System Work With BTK Balloon Angioplasty: TOBA II BTK-Pivotal Trial Results For A BTK Tack Implant |
| Presenter(s):Patrick J. Geraghty, MD / George L. Adams, MD | |
| View Slides in PDF | |
| 2:39 PM - 2:44 PM | Management Of Arterial Dissections Following PTA Is Cost Effective: Results Of An Analysis With The Intact (Tack) Vascular Device |
| Presenter(s):Peter A. Schneider, MD / Michael R. Jaff, DO | |
| View Slides in PDF | |
| PROGRESS IN ATHERECTOMY | |
| 2:44 PM - 2:49 PM | The Phoenix Atherectomy System (From Volcano-Philips): What Makes It Different And Possibly Better Than Other Atherectomy Devices |
| Presenter(s):Miguel F. Montero-Baker, MD | |
| View Slides in PDF | |
| 2:49 PM - 2:54 PM | IVUS Directed Atherectomy Of BTK Lesions With The Phoenix Atherectomy (ATX) Device: Why It Works Better Than Other ATX Devices: Technical Tips And Results Of The PRESTIGE PILOT Trial |
| Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Jetstream Atherectomy (Boston Scientific) With Active Aspiration And DCBs For Use With DCBs For Complex SFA Lesions: What Makes It Different And Advantageous: Technical Tips |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 2:59 PM - 3:04 PM | Value Of Lithotripsy, Orbital Atherectomy (From CSI) And DCBs For Long Calcified BTK Occlusive Lesions: How Do They Work In Concert And Why Do They Promise Good Results |
| Presenter(s):Erwin Blessing, MD | |
| View Slides in PDF | |
| 3:04 PM - 3:09 PM | Improvements In The Turbopowered Laser Atherectomy Device (From Philips): What Makes It Different: How Does It Work With Various Lesion Pathologies: 12-Month Results And IVUS Evaluations |
| Presenter(s):George L. Adams, MD | |
| View Slides in PDF | |
| 3:09 PM - 3:15 PM | Panel Discussion |
| 3:15 PM - 3:25 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 60 | |
| SESSION 61 SCHEDULE | |
|
Thursday
SESSION 61:
UPDATES ON ANCHORING DEVICES (ENDOANCHORS) TO PREVENT OR TREAT ENDOLEAKS WITH EVAR OR TO PREVENT DEVICE MIGRATION
Moderators:William D. Jordan Jr., MD / Jean-Paul de Vries, MD, PhD
|
|
| x | |
| ENDOANCHORS AND EVAR | |
| 3:25 PM - 3:30 PM | New Developments With Endoanchors (Aptus-Medtronic): New Evidence That Endoanchors Can Facilitate And Maintain Successful Standard EVAR For AAAs With Short Or Angulated Necks Without Increasing Costs: From The ANCHOR Registry |
| Presenter(s):William D. Jordan Jr., MD | |
| View Slides in PDF | |
| 3:31 PM - 3:36 PM | When Are Endoanchors Indicated And When Are They Contraindicated: Causes Of Failure And Technical Tips For Optimal Use |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| 3:37 PM - 3:42 PM | Computational Analysis Of AAA Neck Seal Zone Preservation With EVAR And Predicting The Need For Endoanchors To Prevent Migration With Imperfect Necks: Is It Valid |
| Presenter(s):Ross Milner, MD | |
| View Slides in PDF | |
| 3:43 PM - 3:48 PM | Sac Regression Is Important, And Endoanchors May Be Of Benefit In Hostile Necks |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 3:49 PM - 3:54 PM | How Can 3D Fusion Imaging Help In Precision Deployment Of Endoanchors: Does It Improve Outcomes |
| Presenter(s):Giovanni Pratesi, MD | |
| View Slides in PDF | |
| 3:55 PM - 4:00 PM | With Hostile Neck Anatomy Endoanchors Prevent Neck Related Complications – Dilatation, Endoleaks And Migration: What Is The Proof: From The ANCHOR Registry |
| Presenter(s):Apostolos K. Tassiopoulos, MD | |
| View Slides in PDF | |
| 4:01 PM - 4:06 PM | When Can Endoanchors Placed Secondarily Fix Established Type 1A Endoleaks After EVAR: And When Can’t They: What Is The Durability Of Endoanchor Fixes |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| ENDOANCHORS AND TEVAR | |
| 4:07 PM - 4:12 PM | Value Of Endoanchors To Fix Type 1 Endoleaks After TEVAR |
| Presenter(s):Piotr M. Kasprzak, MD | |
| View Slides in PDF | |
| 4:13 PM - 4:18 PM | Value Of Endoanchors With TEVAR: They Decrease The Incidence Of Type 1 Endoleaks And Migration: When Should They Be Used |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 4:19 PM - 4:25 PM | Panel Discussion |
| END OF SESSION 61 | |
| SESSION 62 SCHEDULE | |
|
Thursday
SESSION 62:
NEW OR IMPROVED DEVICES FOR REMOVING DISEASE RELATED OR IATROGENIC CLOT; NEW DEVICES FOR INTRA-ARTERIAL EMBOLIZATION (4 ľ- MINUTE TALKS)
Moderators:Frank R. Arko, MD / James F. Benenati, MD
|
|
| x | |
| CLOT REMOVING DEVICES | |
| 4:25 PM - 4:30 PM | Inari ClotTriever Device For Quick Removal Of Large Amounts Of Intravascular Clot From Large Arteries And Veins: How Does It Work And Advantages |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | Value Of The Rotarex Device (Straub Medical) For Removing Thrombus And Atheromatous Material From Fempop Occlusions: Advantages, Limitations And Technical Tips |
| Presenter(s):Michael K.W. Lichtenberg, MD / Christian Wissgott, MD | |
| View Slides in PDF | |
| 4:35 PM - 4:40 PM | New Findings For Removing Clot With Microbubbles Ultrasound And Thrombolytic Drugs: Its Safer And More Efficient Than Other Lytic Methods |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Latest Innovations And Advances In Endovascular Power Clot Removal/Aspiration: How They Work And Why They Work Better Than Older Devices |
| Presenter(s):James F. Benenati, MD | |
| View Slides in PDF | |
| 4:45 PM - 4:50 PM | Pros And Cons Of Percutaneous Clot Removal Techniques: When Do They Work And When Don’t They |
| Presenter(s):Laura Capoccia, MD, PhD / Michel Rossi, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | Update On The Treatment Of Acute Limb Ischemia: Advantages And Limitations Of The New Endovascular Devices: Are Open Techniques Ever Required |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 4:55 PM - 5:00 PM | The New Endovascular Pharmaco-Mechanical Thrombectomy Devices: How Each Works And Advantages Of Each Device And When Is Each Best |
| Presenter(s):Guillermo A. Escobar, MD | |
| View Slides in PDF | |
| 5:00 PM - 5:06 PM | Panel Discussion |
| 5:06 PM - 5:11 PM | Update On New Technologies For Percutaneous Arterial Clot Aspiration: How Each Works And How Best To Use It: Technical Tips And Limitations |
| Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
| View Slides in PDF | |
| 5:11 PM - 5:16 PM | Multiple Uses Of The Indigo Percutaneous Clot Aspiration System (From Penumbra): How It Works And Why It Simplifies Treatment And Improves Outcomes |
| Presenter(s):Frank R. Arko, MD | |
| View Slides in PDF | |
| 5:16 PM - 5:21 PM | Value Of Arterial Thrombolysis In Patients With Contraindications: How To Do It With Reasonable Safety |
| Presenter(s):Anil P. Hingorani, MD | |
| View Slides in PDF | |
| 5:21 PM - 5:26 PM | Improving Outcomes Of Treatment Of Long Segment Fempop Chronic Occlusions (CTOs) With Initial Indigo Clot Aspiration Before Definitive Use Of A DCB Or Stent |
| Presenter(s):Mazin Foteh, MD | |
| View Slides in PDF | |
| 5:27 PM - 5:32 PM | Mechanical Percutaneous Aspiration Thrombectomy With The Indigo System Is Safe And Effective In Treating Acute Limb Ischemia: When Is It Not: From the Multicenter INDIAN Registry |
| Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD | |
| View Slides in PDF | |
| ADVANCES IN EMBOLOTHERAPY | |
| 5:33 PM - 5:38 PM | Endovascular Treatment Of Visceral And Renal Aneurysms With Detachable Coils: Technical Tips, Limitations And Results |
| Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR | |
| View Slides in PDF | |
| 5:39 PM - 5:44 PM | How To Manage Serious Hemorrhage With Newer Coils And Liquid Embolic Agents |
| Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
| View Slides in PDF | |
| 5:45 PM - 5:52 PM | Panel DiscussionEnd of Program H |
| END OF SESSION 62 | |
| SESSION 63 SCHEDULE | |
|
Thursday
SESSION 63:
VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
|
|
| x | |
| 7:00 AM - 7:04 AM | Introduction To Veins At VEITH |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| 7:05 AM - 7:10 AM | Classification Of Chronic Venous Disease: CEAP, VCSS And Beyond |
| Presenter(s):Marc A. Passman, MD | |
| View Slides in PDF | |
| 7:11 AM - 7:16 AM | VCSS Versus Villata – Pros And Cons As An Outcome Measure |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 7:17 AM - 7:22 AM | Physiology Of Venous Return |
| Presenter(s):Brajesh K. Lal, MD | |
| View Slides in PDF | |
| 7:23 AM - 7:28 AM | Analysis Of Biofluids From Patients With CVD |
| Presenter(s):Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 7:29 AM - 7:34 AM | Lower Limb Venous Kinetics And Impact On Venous Drainage |
| Presenter(s):Sergio Gianesini, MD, PhD, FACS | |
| View Slides in PDF | |
| 7:35 AM - 7:40 AM | An Algorithm To Predict Disease Severity In C2 Patients |
| Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
| View Slides in PDF | |
| 7:41 AM - 7:46 AM | Evidence Summary On The Pathophysiology Of Varicose Veins |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 7:47 AM - 7:52 AM | Understanding Effects Of External Positive And Negative Pressure On The Venous System |
| Presenter(s):Seshadri Raju, MD | |
| View Slides in PDF | |
| 7:53 AM - 7:58 AM | Non-Venous Causes Of The Swollen Extremity |
| Presenter(s):Andrea T. Obi, MD | |
| View Slides in PDF | |
| 7:59 AM - 8:04 AM | Superficial Reflux With Obstructed Deep Veins: When And When Not To Treat |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 8:05 AM - 8:10 AM | Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved |
| Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
| View Slides in PDF | |
| 8:11 AM - 8:16 AM | Panel Discussion |
| END OF SESSION 63 | |
| SESSION 64 SCHEDULE | |
|
Thursday
SESSION 64:
VENOUS IMAGING TECHNIQUES
Moderators:Jose I. Almeida, MD, FACS, RPVI, RVT / Paul J. Gagne, MD
|
|
| x | |
| 8:17 AM - 8:22 AM | Identifying Reflux Pathways With Duplex Ultrasound Mapping |
| Presenter(s):Neil M. Khilnani, MD | |
| View Slides in PDF | |
| 8:23 AM - 8:28 AM | Iliocaval Duplex Ultrasound With Image Optimization |
| Presenter(s):Jan M. Sloves, RVT | |
| View Slides in PDF | |
| 8:29 AM - 8:34 AM | Getting A Look At Inflow With Duplex Ultrasound Prior To Endovascular Reconstruction Of Post-Thrombotic Iliocaval Disease |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 8:35 AM - 8:40 AM | MRV And Major Venous Interventions |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 8:41 AM - 8:46 AM | Single Center Retrospective Review Of Patients With Iliac Thrombosis Who Underwent CT And DUS .... Showing The Limitations Of DUS |
| Presenter(s):Heron E. Rodriguez, MD | |
| View Slides in PDF | |
| 8:47 AM - 8:52 AM | Value Of IVUS And Other Techniques To Improve The Diagnosis And Treatment Of Iliofemoral Occlusion |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 8:53 AM - 8:58 AM | Detailed Anatomy Of The Gastrocnemius And Soleus Veins Based On CT-Venography |
| Presenter(s):Evgeny Shaydakov, MD, PhD | |
| View Slides in PDF | |
| 8:59 AM - 9:04 AM | The VIDIO Trial Comparing IVUS Versus Multiplanar Venogram For Diagnosing Iliofemoral Vein Obstruction |
| Presenter(s):Paul J. Gagne, MD | |
| View Slides in PDF | |
| 9:05 AM - 9:10 AM | Transillumination Phleboscopy: What Do We Need To Avoid |
| Presenter(s):Gutenberg A. Gurgel, MD | |
| View Slides in PDF | |
| 9:11 AM - 9:16 AM | Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease |
| Presenter(s):Seshadri Raju, MD | |
| View Slides in PDF | |
| 9:17 AM - 9:22 AM | Panel Discussion |
| END OF SESSION 64 | |
| SESSION 65 SCHEDULE | |
|
Thursday
SESSION 65:
SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
|
|
| x | |
| 9:23 AM - 9:28 AM | Venous Drugs And Do They Work – The Colombian Experience |
| Presenter(s):Jorge H. Ulloa, MD, FACS | |
| View Slides in PDF | |
| 9:29 AM - 9:34 AM | What Drugs Do I Recommend For Symptomatic Venous Disease |
| Presenter(s):Alberto C. Duque, MD | |
| View Slides in PDF | |
| 9:35 AM - 9:40 AM | "Choosing Wisely" Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence |
| Presenter(s):Claudine M. Hamel-Desnos, MD | |
| View Slides in PDF | |
| 9:41 AM - 9:46 AM | Truncal Vein Diameters Should Not Be Used As A Rationing Tool |
| Presenter(s):Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 9:47 AM - 9:52 AM | Combined Ablation Plus Phlebectomy Is Associated With Improvements In Venous Outcomes |
| Presenter(s):Nicholas H. Osborne, MD, MS | |
| View Slides in PDF | |
| 9:53 AM - 9:58 AM | Long-Term (25 Years) Results Of Venopreserving Operations |
| Presenter(s):Evgeny Shaydakov, MD, PhD | |
| View Slides in PDF | |
| 9:59 AM - 10:04 AM | Polidocanol Foam Sclerotherapy Of Lymphoceles After Varicose Vein Surgery: An Effective And Safe First-Choice Treatment |
| Presenter(s):Lourdes Reina, MD | |
| View Slides in PDF | |
| 10:05 AM - 10:10 AM | Do You Need To Treat EHIT 2 |
| Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | SVT In The Pregnant Patient |
| Presenter(s):Ellen D. Dillavou, MD | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Saphenous Vein Histopathology 5.5 Years After Cyanoacrylate Closure |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | Radiofrequency And Laser Vein Ablation For Patients On Anticoagulation Is Safe, Effective, And Durable |
| Presenter(s):Glenn Jacobowitz, MD | |
| View Slides in PDF | |
| 10:29 AM - 10:34 AM | Panel Discussion |
| END OF SESSION 65 | |
| SESSION 66 SCHEDULE | |
|
Thursday
SESSION 66:
THERMAL AND NON-THERMAL ABLATION
|
|
| x | |
| 10:35 AM - 10:40 AM | Ultrasound Guided Foam Sclerotherapy: What We Should Know |
| Presenter(s):Jean Luc Gerard, MD | |
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | Is Thermal Ablation Obsolete |
| Presenter(s):Kathleen D. Gibson, MD | |
| View Slides in PDF | |
| 10:47 AM - 10:52 AM | Radiofrequency Ablation: Something New |
| Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
| View Slides in PDF | |
| 10:53 AM - 10:58 AM | VenaSealTM Closure System Post Procedure Care |
| Presenter(s):Brian Ferris, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:04 AM | Proprietary Polidocanol Microfoam: What We Should Know |
| Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | SECURE Trial Update |
| Presenter(s):Mark A. Adelman, MD | |
| View Slides in PDF | |
| 11:11 AM - 11:16 AM | New Venous Closure Devices: Mechanical |
| Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
| View Slides in PDF | |
| 11:17 AM - 11:22 AM | Contraindications And Limits: MOCA |
| Presenter(s):Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | Contraindications And Limits: Laser |
| Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
| View Slides in PDF | |
| 11:29 AM - 11:34 AM | Contraindications And Limits: Radiofrequency Ablation |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | Panel Discussion |
| END OF SESSION 66 | |
| SESSION 67 SCHEDULE | |
|
Thursday
SESSION 67:
SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
Moderators:Edward G. Mackay, MD / Jean Luc Gerard, MD
|
|
| x | |
| 11:41 AM - 11:46 AM | Morel Lavallée Syndrome |
| Presenter(s):Jean Luc Gerard, MD | |
| View Slides in PDF | |
| 11:47 AM - 11:52 AM | Laser Or Ohmic Devices For Telangiectasia: When And Why |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 11:53 AM - 11:58 AM | Phlebectomy: Step By Step |
| Presenter(s):Saum A. Rahimi, MD | |
| View Slides in PDF | |
| 11:59 AM - 12:04 PM | Ablative Risks Prior And After Flying: What Do You Tell Your Patients |
| Presenter(s):Sarah Onida, MD, PhD | |
| View Slides in PDF | |
| 12:05 PM - 12:10 PM | Foam Therapies (PCF Vs PEM): When To Use And Does It Make A Difference |
| Presenter(s):Edward G. Mackay, MD | |
| View Slides in PDF | |
| 12:11 PM - 12:16 PM | How To Treat Labial Varices: Sclerotherapy, USG Sclerotherapy And/Or Phlebectomy |
| Presenter(s):Ellen D. Dillavou, MD | |
| View Slides in PDF | |
| 12:17 PM - 12:22 PM | Should All Saphenous Recanalizations Be Treated |
| Presenter(s):Kathleen D. Gibson, MD | |
| View Slides in PDF | |
| 12:23 PM - 12:28 PM | Laser And/Or Sclerosant For Cosmetic Veins: How And Why |
| Presenter(s):Gutenberg A. Gurgel, MD | |
| View Slides in PDF | |
| 12:29 PM - 12:34 PM | Panel Discussion |
| 12:35 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 67 | |
| SESSION 68 SCHEDULE | |
|
Thursday
SESSION 68:
VENOUS SOCIETAL AND GOVERNANCE
Moderators:Kathleen J. Ozsvath, MD / Harold J. Welch, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | CMS Policy Update On Nonthermal Ablation |
| Presenter(s):Harold J. Welch, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | The Future Of Venous Reimbursement In A Non-Fee For Service Environment |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | What Are The Next Venous Trials |
| Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Diametric Opposite CMS Trends In Arterial And Venous Procedures: Implications For Manpower And Training |
| Presenter(s):Thomas F. O'Donnell, Jr., MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | Is The Vein Center Accreditation Important For MACRA |
| Presenter(s):Kathleen J. Ozsvath, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Update On Deep Venous Accreditation |
| Presenter(s):Stephen F. Daugherty, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Appropriateness In Venous Surgery - What's The Problem |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | How Can Appropriate Use Criteria Help Curb Inappropriate Venous Care |
| Presenter(s):Elna M. Masuda, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Results Of Appropriateness Criteria (AVF) II |
| Presenter(s):Kathleen J. Ozsvath, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Can VQI Be Used As A Benchmark For Setting Ethical Standards |